


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:50:06Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407648" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407648</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>gmic</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Gut Microbes</journal-id><journal-id journal-id-type="iso-abbrev">Gut Microbes</journal-id><journal-id journal-id-type="pmc-domain-id">1365</journal-id><journal-id journal-id-type="pmc-domain">gmic</journal-id><journal-title-group><journal-title>Gut Microbes</journal-title></journal-title-group><issn pub-type="ppub">1949-0976</issn><issn pub-type="epub">1949-0984</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407648</article-id><article-id pub-id-type="pmcid-ver">PMC12407648.1</article-id><article-id pub-id-type="pmcaid">12407648</article-id><article-id pub-id-type="pmcaiid">12407648</article-id><article-id pub-id-type="pmid">40887742</article-id><article-id pub-id-type="doi">10.1080/19490976.2025.2551117</article-id><article-id pub-id-type="publisher-id">2551117</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Review: microbial metabolites &#8211; a key to address gut inflammation and barrier dysfunction in the premature infant</article-title><alt-title alt-title-type="left-running-head">K. M. ROBERTSON ET AL.</alt-title><alt-title alt-title-type="right-running-head">GUT MICROBES</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4169-9041</contrib-id><name name-style="western"><surname>Robertson</surname><given-names initials="KM">Katharina M.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cermack</surname><given-names initials="K">Katherine</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Woodruff</surname><given-names initials="T">Talia</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/" vocab-term="Visualization">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-5233-4184</contrib-id><name name-style="western"><surname>Carter</surname><given-names initials="SR">Stewart R.</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/" vocab-term="Supervision">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jala</surname><given-names initials="VR">Venkatakrishna Rao</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/" vocab-term="Supervision">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7809-886X</contrib-id><name name-style="western"><surname>Buonpane</surname><given-names initials="C">Christie</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0001" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/" vocab-term="Conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/" vocab-term="Supervision">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><aff id="aff0001"><label>a</label>Division of Pediatric Surgery, <institution-wrap><institution>Norton Children&#8217;s Hospital/University of Louisville</institution></institution-wrap>, <city>Louisville</city>, <state>KY</state>, <country>USA</country></aff><aff id="aff0002"><label>b</label>Pediatric Research Institute, Department of Pediatrics, <institution-wrap><institution>University of Louisville</institution></institution-wrap>, <city>Louisville</city>, <state>KY</state>, <country>USA</country></aff><aff id="aff0003"><label>c</label>Department of Microbiology and Immunology, UofL-Brown Cancer Center, <institution-wrap><institution>University of Louisville</institution></institution-wrap>, <city>Louisville</city>, <state>KY</state>, <country>USA</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Christie Buonpane <email xlink:href="mailto:christie.buonpane@louisville.edu">christie.buonpane@louisville.edu</email> The Hiram C. Polk Jr, MD Department of Surgery, Division of Pediatric Surgery, Norton Children&#8217;s Hospital/University of Louisville, <addr-line>550 South Jackson Street</addr-line>, <city>Louisville</city>, <state>KY</state><postal-code>40202</postal-code>, <country>USA</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>8</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>17</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">477378</issue-id><elocation-id seq="311">2551117</elocation-id><pub-history><event event-type="pmc-release"><date><day>31</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 16:25:19.050"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="tagger"><event-desc>Integra</event-desc><date><day>01</day><month>9</month><year>2025</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>01</day><month>9</month><year>2025</year></date></event><event event-type="received"><date><day>01</day><month>5</month><year>2025</year></date></event><event event-type="revised"><date><day>03</day><month>8</month><year>2025</year></date></event><event event-type="accepted"><date><day>13</day><month>8</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published with license by Taylor &amp; Francis Group, LLC.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="KGMI_17_2551117.pdf"/><self-uri content-type="pdf" xlink:href="KGMI_17_2551117.pdf"/><abstract><title>ABSTRACT</title><p>Preterm birth interrupts the development of the human gastrointestinal tract, resulting in an immature permeable gut barrier with increased risk of intestinal pathology, such as necrotizing enterocolitis (NEC). The gut microbiota metabolize dietary components into bioactive metabolites that play a crucial role in maintaining intestinal homeostasis. While the roles of microbial metabolites have been studied in relation to adult gastrointestinal diseases, their specific impact on preterm infants remains unexplored. This review aims to identify how microbial metabolites interact with the developing gut barrier in preterm infants, focusing on their role in gut inflammation and NEC. Metabolites include short-chain and conjugated fatty acids, indole derivatives, bile acids, polyamines, and polyphenolic compounds. An overview of the unique features of the premature gut barrier physiology is provided, including perinatal developmental changes in cellular structure, cell junctions, and the gut microbiome. Potential benefits and molecular mechanisms of microbial metabolites in the premature intestine and environmental factors responsible for NEC are discussed. In summary, microbiome-derived mediators have the potential to strengthen preterm gut barrier integrity and alleviate inflammatory stress. Further research may reveal clinically relevant preventative or therapeutic treatment targets for NEC in preterm infants.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Gut microbiome</kwd><kwd>microbial metabolites</kwd><kwd>preterm infants</kwd><kwd>necrotizing enterocolitis</kwd><kwd>NEC</kwd></kwd-group><support-group><funding-group><funding-statement>No funding was received to assist with the preparation of this manuscript.</funding-statement></funding-group></support-group><counts><fig-count count="2"/><table-count count="3"/><ref-count count="174"/><page-count count="1"/><word-count count="11636"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><title>Introduction</title><p>The human gut is a highly specialized interface between the external environment and the host, which has a significant impact on human health. The gut lining exerts a complex dual function incorporating barrier defense against environmental factors as well as selective barrier permeability for dietary components. Preterm birth interrupts the development of the human gastrointestinal tract during the final trimesters of pregnancy, resulting in an immature permeable gut barrier with increased risk of intestinal diseases.<sup><xref rid="cit0001" ref-type="bibr">1</xref></sup> A mucosal layer, submucosal immune system, and epithelial cell layer form a chemical, immunological, and physical barrier against potential pathogens, food antigens, or toxins.<sup><xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0003" ref-type="bibr">3</xref></sup> Simultaneously, the gut barrier allows for transport of essential molecules to provide nutrients to the host.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> This requires maintenance of a multi-layered signaling system based on dynamic epithelial barrier integrity, a balanced symbiotic relationship with commensal bacteria, and an adequate immune response.<sup><xref rid="cit0002" ref-type="bibr">2</xref></sup> The premature gut barrier is characterized by a low production of mucin,<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> a dysfunctional integrity of the epithelial layer of the gut,<sup><xref rid="cit0005" ref-type="bibr">5</xref></sup> and an insufficient intestinal immune response.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup></p><p>Necrotizing enterocolitis (NEC) is a life-threatening inflammatory condition in premature infants, leading to acute intestinal ischemia and necrosis. NEC is the prevailing cause of morbidity and mortality in 5&#8211;7% of preterm neonates and 10&#8211;15% of very low birth weight infants.<sup><xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0008" ref-type="bibr">8</xref></sup> Surgery is required in approximately 50% of affected infants, with associated mortality rates of up to 51%.<sup><xref rid="cit0009" ref-type="bibr">9</xref></sup> Despite the fulminant course of surgical NEC and research investigating its pivotal role in premature infants, specific treatment strategies have yet to be established. The pathogenesis of NEC is multifactorial and characterized by gut barrier dysfunction due to an imbalanced interplay between mucus production, epithelial (enterocyte) cell integrity and immune response.<sup><xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0011" ref-type="bibr">11</xref></sup></p><p>Microbial metabolites are produced by the gut microbiota and have a pivotal role in gastrointestinal maturity, pathogen colonization, gut barrier integrity, and host metabolism.<sup><xref rid="cit0012" ref-type="bibr">12</xref></sup> Active metabolites can have a direct impact on the gut barrier by upregulating tight junction proteins (TJs),<sup><xref rid="cit0012" ref-type="bibr">12</xref></sup> altering cellular metabolism, and modulating the immune response to inhibit or promote inflammation.<sup><xref rid="cit0013" ref-type="bibr">13</xref></sup> Microbial metabolites have been reported to play a central role in intestinal barrier function and associated inflammatory and metabolic diseases, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, and colon cancer.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0015" ref-type="bibr">15</xref></sup> However, their role in the premature intestinal barrier poorly investigated.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup></p><p>We postulate that microbial metabolites and the associated molecular mechanisms that play a role in adult intestinal inflammation may also have an impact on the premature gut barrier and NEC pathogenesis. This review aims to explore how microbial metabolites may interact with the developing gut barrier in premature infants. Applying concepts from the role of microbial metabolites with adult intestinal physiology could reveal new insights into NEC pathogenesis and treatment.</p></sec><sec disp-level="1" id="s0002"><title>Intestinal immaturity and gastrointestinal development</title><p>The gastrointestinal tract develops during the second and third trimester of pregnancy with tremendous growth of the intestine, increasing one-thousand-fold in size from gestational weeks 5 to 40.<sup><xref rid="cit0016" ref-type="bibr">16</xref></sup> Small intestine growth continues into adulthood, reaching an approximate length of 575&#8201;cm by age 20&#8201;years, with a total surface area of 200&#8201;m<sup>2</sup>. Interrupted development in infants born prematurely can severely impact structural and functional maturation of the gastrointestinal tract. The underdeveloped nervous system delays intestinal transit, facilitating bacterial overgrowth and abdominal distension due to increased fermentation and gas production.<sup><xref rid="cit0017" ref-type="bibr">17</xref></sup> This stasis, in combination with a premature barrier characterized by low protective mucus, decreased secretory immunoglobulin A production, and reduced regenerative capabilities increase the risk for inflammation and tissue damage.<sup><xref rid="cit0017" ref-type="bibr">17</xref></sup> An immature gut immune system and increased gut barrier permeability predispose neonates for bacterial translocation, intestinal inflammation, and NEC.<sup><xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0017" ref-type="bibr">17</xref></sup></p><p>The intestinal barrier is comprised of three layers: a luminal mucus layer, an epithelial layer, and a submucosal immune system of the gut, all of which work to provide physical and immunological protection<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> (<xref rid="f0001" ref-type="fig">Figure 1</xref>). The selective permeability of the gut barrier allows the passage of beneficial metabolites such as nutrients and electrolytes while protecting against pathogenic bacteria and toxins.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0018" ref-type="bibr">18</xref></sup> Premature intestine shows deficiencies in all three of these layers, leading to insufficient host defense and activation of inflammatory cascades.
<fig position="float" id="f0001" fig-type="figure" orientation="portrait"><label>Figure 1.</label><caption><p>Intestinal barrier anatomy and physiology.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KGMI_A_2551117_F0001_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KGMI_A_2551117_F0001_PB.jpg"/></alternatives><attrib>Structure and function of the mature intestinal barrier (left) and known premature barrier physiology (right). The layers of the barrier consist of the intestinal lumen, mucus layer, epithelial lining, and lamina propria. The epithelium shows enterocytes, goblet cells tuft cells, enteroendocrine cells, and Paneth cells. The structure of cell junction is demonstrated in the left bottom corner.</attrib><attrib>Alterations in barrier physiology specific to the premature intestine are listed on the right.</attrib><attrib>IAP&#8201;=&#8201;Intestinal alkaline phosphatase; NEC&#8201;=&#8201;Necrotizing enterocolitis</attrib></fig></p><sec disp-level="2" id="s0002-s2001"><title>Luminal mucosal layer</title><p>The mucosal layer of the intestinal barriers is composed of glycoproteins formed from the secretion of mucins by goblet cells.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> The presence of pathogens in the intestinal environment can stimulate release of mucins by the goblet cells to increase protection against infections and parasitic invasions.<sup><xref rid="cit0019" ref-type="bibr">19</xref></sup> Secretion of interleukin (IL-25) by tuft cells triggers subsequent release of IL-13, a cytokine that promotes a hyperplastic response by goblet cells to increase mucin release.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Furthermore, goblet cells release antimicrobial peptides and are able to provide intestinal immune cells with antigens via Goblin cell-associated antigen passages.<sup><xref rid="cit0020" ref-type="bibr">20</xref></sup> The premature mucosal layer is characterized by a reduced capacity of goblet cells to produce mucin, resulting in a thinner mucus layer and increased barrier permeability as well as inflammation.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup></p></sec><sec disp-level="2" id="s0002-s2002"><title>Epithelial layer</title><p>The epithelial layer consists of a single layer of epithelial cells and cell junctions and has a central role in gut barrier regulation.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Some of the most important specialized intestinal epithelial cells (IECs) include enterocytes, Paneth cells, goblet cells, enteroendocrine cells, and tuft cells.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In addition to their individual functions, they collectively play a role in maintenance and regulation of intestinal barrier permeability. The presence of these cells forms a polarized monolayer which functions to separate the intestinal lumen from the underlying lamina propria.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> Due to the impermeability of the IEC cellular membranes to hydrophilic solutes, these molecules are unable to cross the barrier without the use of specific transporters.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> The epithelial structure consists of crypts and villi, with proliferating intestinal stem cells (ISCs) that are high in Leucine-rich repeat-containing G-protein coupled receptor 5 (<italic toggle="yes">LGR5</italic>) expression at the crypt base. LGR5 marks actively dividing stem cells in the intestinal crypts, essential for intestinal development. The cells differentiate, progressively migrate to the villus tip, and then slough into the intestinal lumen via anoikis (apoptosis), which ensures epithelial renewal of eventually damaged cells every 5&#8201;days.<sup><xref rid="cit0021" ref-type="bibr">21</xref></sup> The crypt-villus architecture in preterm infants has not yet been fully organized and enterocyte differentiation is not yet localized in the base of the crypts.<sup><xref rid="cit0020" ref-type="bibr">20</xref></sup> At 10&#8201;weeks gestation, <italic toggle="yes">LGR5</italic> expression can be demonstrated throughout the intestine and enterocytes differentiate from stem-cell-like cells that are low in <italic toggle="yes">LGR5</italic>.<sup><xref rid="cit0020" ref-type="bibr">20</xref></sup> At 12&#8201;weeks, LGR5+ progenitors have started to organize in crypt bases and increase in frequency until 19+ weeks of gestation.<sup><xref rid="cit0020" ref-type="bibr">20</xref></sup> In preterm infants, the epithelial layer still consists of an abundance of ISCs and reduced numbers of differentiated specialized epithelial cells, which contributes to barrier dysfunction.<sup><xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0022" ref-type="bibr">22</xref></sup></p><p>Enterocytes and their corresponding junctional proteins create the physical barrier of both the small and large intestines.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Enterocytes are also responsible for absorption of nutrients and their reciprocal metabolization, further enhancing their role in regulation of intestinal permeability.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0019" ref-type="bibr">19</xref></sup> Following nutrient acquisition, enteroendocrine cells are responsible for the release of peptide hormones for regulation of digestive processes of the gastrointestinal system.<sup><xref rid="cit0023" ref-type="bibr">23</xref></sup> These processes are essential for nutrient metabolism and to provide the body with the necessary energy to carry out its basic functions. Protection against pathogens is a crucial function of some IECs. The production of antimicrobial peptides by Paneth cells is essential for regulating intestinal homeostasis by protecting against pathogenic species.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Paneth cells are located at the base of the small intestinal crypts in proximity to intestinal stem cells.<sup><xref rid="cit0021" ref-type="bibr">21</xref></sup> They secrete lysozyme, phospholipase A2, and antimicrobial peptides (defensins &#945; and &#946;) as well as cathelicidins to regulate microbiota composition.<sup><xref rid="cit0021" ref-type="bibr">21</xref></sup> Defensins released into the intestinal crypt by Paneth cells can induce chloride secretion from neighboring enterocytes to flush potential pathogens away from the sensitive stem cells.<sup><xref rid="cit0021" ref-type="bibr">21</xref></sup> Paneth cells can be found at 13.5&#8201;weeks of gestation at a low density which gradually increases until term.<sup><xref rid="cit0024" ref-type="bibr">24</xref></sup> During their cell development at 20&#8211;28&#8201;weeks of gestation, cathelicidin expression decreases significantly, which is associated with a higher susceptibility to NEC. Compared to age-matched controls, premature infants have fewer and mostly underdeveloped Paneth cells that are not immunocompetent,<sup><xref rid="cit0025" ref-type="bibr">25</xref></sup> which leads to an altered microbiome and increased risk for inflammation.</p><p>In addition to the specialized epithelial cells of the intestinal immune system, cellular junctions regulate the passage of molecules between cells of the gut barrier.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> These junctional complexes can be categorized as TJs, adherens junctions (AJs), and desmosomes.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> TJs are located on the apical surface of the epithelium and contain proteins necessary for maintenance of cell-to-cell adhesion and molecular transport.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0018" ref-type="bibr">18</xref></sup> Occludins, zonula occludens (ZO), and claudins are integral membrane proteins of the TJ complex. TJs of the premature gut are characterized by an immature composition and function, suspectedly involving occludin&#8211;claudin interaction, which may increase barrier permeability in preterm infants.<sup><xref rid="cit0026" ref-type="bibr">26</xref></sup></p><p>Occludin is a 65 kDa protein and was identified as the first TJ strand component.<sup><xref rid="cit0027" ref-type="bibr">27</xref></sup> Occludins exert a regulatory function rather than being responsible for TJ strand formation.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> In occludin gene knockout mice, TJs remained present, but mice showed significant defects, such as chronic gastritis, hearing loss, brain calcifications, male infertility, and failure of females to adequately suckle pups.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup></p><p>ZO and claudins are integral to the maintenance of the apical epithelial structure of the TJ complex.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> In ZO-1 and ZO-2 knockout epithelial cell lineages, gut barrier function was impaired due to the inability to recruit <italic toggle="yes">claudins</italic> to the TJ complex.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup> Claudins form pores to regulate permeability of the complex.<sup><xref rid="cit0029" ref-type="bibr">29</xref></sup> Despite initial loss of barrier maintenance and disrupted cytoskeletal organization in ZO-1/ZO-2 knockout cells, function was restored by increasing ZO-1 expression and reinstating claudin binding.<sup><xref rid="cit0028" ref-type="bibr">28</xref></sup></p><p>Along with TJs and their peptide components, AJs and desmosomes function to maintain epithelial structure and thus play a role in intestinal barrier permeability.<sup><xref rid="cit0018" ref-type="bibr">18</xref></sup> AJ proteins consist of cadherins and catenins, while peptide components of desmosomes include desmoglein and desmocollins.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> The inhibition or deficiency of the protein components of both AJs and desmosomes has been shown to cause worsening of the integrity of the gut barrier. Specific to AJs, inhibition of the E-cadherin-catenin complex results in weakening of the intestinal mucosal barrier.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In desmosomes, deficiency of desmoglein 2 results in loss of epithelial layer integrity in the gut barrier.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup></p><p>The intestinal barrier is supposed to tighten and become more selectively permeable in early postnatal maturation independent of gestational age. Commensal bacteria induce expression of genes that improve intestinal barrier function and abnormal colonization can disrupt this process. Therefore, premature neonates with abnormal intestinal microbial composition do not have postnatal maturation of this critical protective barrier, leaving the neonate susceptible to entry of microbes, toxins, inflammation and injury.</p></sec><sec disp-level="2" id="s0002-s2003"><title>Submucosal immune system</title><p>The subepithelial region consists of the <italic toggle="yes">lamina propria</italic> (composed of immune cells), the enteric nervous system, and connective tissue. This area is colonized with B and T cells, eosinophils, dendritic cells, mast cells, macrophages and more. The gut immune cells are organized into lymphoid structures such as lymphatic follicles, Peyer&#8217;s patches and mesenteric lymph nodes. There is an extracellular matrix of the lamina propria that is supported by connective tissue produced by fibroblasts. Finally, there is an enteric nervous system with neurons and glial cells that form the myenteric plexus and the submucosal plexus. This system coordinates the interaction between the central nervous system and the intestine. While the epithelial barrier offers physical protection, mucosal immune function is required to mount a response to harmful antigens. Impairment in the intestinal immune system and its interaction with gut antigens can lead to inflammation and disease.</p><p>The immaturity and level of development of the gut barrier is a crucial factor in the pathogenesis of intestinal disorders such as NEC in the premature infant. <xref rid="t0001" ref-type="table">Table 1</xref> explores the differences in the premature versus the mature intestinal barrier. The complex interplay between the structural and immunological components of the premature gut barrier is a key area of investigation, as its dysregulation plays a significant role in the development of neonatal intestinal disease.<table-wrap position="float" id="t0001" orientation="portrait"><label>Table 1.</label><caption><p>Features of the preterm versus mature intestinal tract and gut barrier.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Preterm intestine</th><th align="center" colspan="1" rowspan="1">Mature intestine</th><th align="center" colspan="1" rowspan="1">Implication in NEC</th></tr></thead><tbody><tr><td colspan="4" align="left" rowspan="1"><italic toggle="yes">Luminal Mucosal Layer</italic></td></tr><tr><td align="left" colspan="1" rowspan="1">Goblet Cells and Mucin Production</td><td align="left" colspan="1" rowspan="1">Fewer goblet cells are present, forming a thinner mucous layer. Mucin 2 expressing goblet cell density remains stable at 8&#8211;10&#8201;weeks gestation. This increases between 12&#8211;19+ weeks.</td><td align="left" colspan="1" rowspan="1">More abundant goblet cells, with a well-formed mucous barrier, promoting a healthy microbiome balance</td><td align="left" colspan="1" rowspan="1">Thin mucous layer leaves preterm infants vulnerable to infections diseases and inflammation, linked to NEC pathogenesis.<break/>MUC1 and 2 are reduced in the intestinal tissue of NEC neonates compared to control preterm without NEC<sup><xref rid="cit0030" ref-type="bibr">30</xref></sup></td></tr><tr><td colspan="4" align="left" rowspan="1"><italic toggle="yes">Epithelial Layer</italic></td></tr><tr><td align="left" colspan="1" rowspan="1">LGR5+</td><td align="left" colspan="1" rowspan="1">LGR5+ progenitor cells are expressed early and drive crypt formation.<break/>Less LGR5+ in the preterm intestine, reduced self-renewal capacity and vulnerability to injury and inflammation</td><td align="left" colspan="1" rowspan="1">High LGR5+ stem population allowing for fully developed crypts, a stem cell niche, reliable epithelial turnover and efficient gut repair after injury</td><td align="left" colspan="1" rowspan="1">Reduced LGR5+, higher crypt stress and apoptosis in NEC<sup><xref rid="cit0031" ref-type="bibr">31</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Paneth Cells</td><td align="left" colspan="1" rowspan="1">Paneth cell development occurs between 20&#8211;28&#8201;weeks gestation. Paneth cell numbers are lower in preterm infants.</td><td align="left" colspan="1" rowspan="1">Paneth cells are present with dense granules containing antimicrobial peptides and immunomodulating proteins that help fight infection. Paneth cells also regulate intestinal flora.</td><td align="left" colspan="1" rowspan="1">Loss of paneth cells causes loss of &#945; defensin, immunoglobulins, microbial homeostasis, disruption of the intestinal barrier, leading to NEC<sup><xref rid="cit0024" ref-type="bibr">24</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Intestinal alkaline phosphatase (IAP)</td><td align="left" colspan="1" rowspan="1">Enterocytes have lower capacity to produce IAP</td><td align="left" colspan="1" rowspan="1">Enterocytes secrete IAP, which detoxifies bacterial products in the intestinal lumen and prevents inflammation</td><td align="left" colspan="1" rowspan="1">Low levels of IAP in the preterm infant leads to dysbiosis, decreased intestinal integrity, decreased intestinal perfusion, leaving them vulnerable to NEC<sup><xref rid="cit0032" ref-type="bibr">32</xref></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Tight Junctions (TJ)</td><td align="left" colspan="1" rowspan="1">Increased barrier permeability due to underdeveloped structure and function of TJs</td><td align="left" colspan="1" rowspan="1">Form functional protein complexes that maintain cell to cell adhesion, molecular transport and barrier integrity</td><td align="left" colspan="1" rowspan="1">There is a downregulation of occludin, claudin-4 and ZO-1 in NEC<sup><xref rid="cit0030" ref-type="bibr">30</xref>,<xref rid="cit0033" ref-type="bibr">33</xref>,<xref rid="cit0034" ref-type="bibr">34</xref></sup></td></tr><tr><td colspan="4" align="left" rowspan="1"><italic toggle="yes">Submucosal Immune System</italic></td></tr><tr><td align="left" colspan="1" rowspan="1">Immune Cells</td><td align="left" colspan="1" rowspan="1">B lymphocytes and IgA concentrations do not reach adult population levels until 2&#8201;years of age. Low levels of intraepithelial lymphocytes.</td><td align="left" colspan="1" rowspan="1">Key immune mediators present that identify and destroy pathogens that have breached the mucus and epithelial barriers.</td><td align="left" colspan="1" rowspan="1">Decreased regulatory T cells, underdeveloped neural network, immature immune cells have been implicated in NEC<sup><xref rid="cit0035" ref-type="bibr">35</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p>LGR5&#8201;=&#8201;Leucine-rich repeat-containing G-protein coupled receptor 5; NEC&#8201;=&#8201;Necrotizing enterocolitis; IAP&#8201;=&#8201;Intestinal alkaline phosphatase.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec disp-level="1" id="s0003"><title>The premature gut microbiome</title><p>The gut microbiome is essential for the function of the intestinal system and protection against infection; however, it is underdeveloped in the premature infant. Several factors that are unique to the premature infant influence the development and diversity of the microbiome of the premature intestinal tract. Colonization and maturation of the infant gut microbiome typically occur in a stepwise fashion, with deviations implicated in several health impairments in childhood and adolescence. Infants born before 37&#8201;weeks&#8217; gestation have a unique set of microbial colonization patterns as well as frequent clinical interventions that modify the gut microbiome.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup> These alterations can subsequently increase the vulnerability of the preterm infant to developing NEC.</p><sec disp-level="2" id="s0003-s2001"><title>Establishment of the neonatal gut microbiome</title><p>Increasing evidence suggests that the neonatal gut microbiome already develops in utero.<sup><xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref></sup> It is therefore potentially altered by both prenatal and postnatal factors, such as microbial composition within the placenta and amniotic fluid, antenatal antibiotic exposure in utero, or postnatal microbial transfer of bacteria through breast milk.<sup><xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref></sup></p><p>The infant&#8217;s microbiome during the first two months of life is dynamic, commonly shows sudden shifts of bacterial populations, and follows a choreographed pattern at varying rates dependent on gestation at birth.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup> A fast increase in facultatively anaerobe Proteobacteria, such as Gammaproteobacteria, Escherichia and Klebsiella, is followed by their slow decline and a continuously increasing proportion of strictly anaerobic bacteria, such as <italic toggle="yes">Bifidobacterium</italic> spp.<sup><xref rid="cit0039" ref-type="bibr">39</xref>,<xref rid="cit0040" ref-type="bibr">40</xref></sup></p><p>A universal microbial signature deviating from this early development pattern that is predicting the onset of NEC or defining NEC itself, however, has yet to be identified.<sup><xref rid="cit0038" ref-type="bibr">38</xref>,<xref rid="cit0041" ref-type="bibr">41</xref></sup> Gut microbiome diversity and a high proportion of Bifidobacterium spp. has been associated with reduced risk of NEC onset.<sup><xref rid="cit0041" ref-type="bibr">41</xref></sup> Furthermore, an association between NEC and strains of the anaerobic toxin-producing Clostridium perfringens has been found.<sup><xref rid="cit0042" ref-type="bibr">42</xref></sup> In infants born at less than 27&#8201;weeks&#8217; gestation developing NEC, an increased proportion of facultatively anaerobe Gammaproteobacteria and a reduced proportion of strictly anaerobic Negativicutes were demonstrated.<sup><xref rid="cit0039" ref-type="bibr">39</xref></sup> Strictly anaerobe Bifidobacterium spp. and <italic toggle="yes">Bacteroides spp</italic>. were also reduced in preterm infants during the first six weeks of life.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup> The My Baby Biome study revealed that even in term infants in the United States, a lack of Bifidobacterium spp. can drive gut dysbiosis and changes metabolic signatures.<sup><xref rid="cit0043" ref-type="bibr">43</xref></sup> The interplay of microbial composition, gut inflammation and NEC pathogenesis has yet to be clarified. One mechanism suggests a dysregulation of inflammatory responses in the preterm gut due to Toll-like receptor 4 (TLR4) activation by gram-negative lipopolysaccharides.<sup><xref rid="cit0044" ref-type="bibr">44</xref></sup> Strain-specific differences between bacterial species add even more complexity to the microbial network, as different bacterial strains drive development of different gut community types and therefore altered stool metabolite profiles.<sup><xref rid="cit0040" ref-type="bibr">40</xref></sup></p><p>Apart from alterations of the preterm gut microbiome, an altered gut virome preceding NEC onset also suggests NEC-associated gut virus-bacteria interactions, particularly related to <italic toggle="yes">Acinetobacter</italic>, <italic toggle="yes">Clostridium</italic>, <italic toggle="yes">Lactobacillus</italic> and <italic toggle="yes">Haemophilus</italic>.<sup><xref rid="cit0044" ref-type="bibr">44</xref></sup> Current evidence, however, is still lacking detailed analysis of overall virome composition and development.</p></sec><sec disp-level="2" id="s0003-s2002"><title>Neonatal intensive care unit admission</title><p>Neonatal microbiome development is affected by time spent in the Neonatal Intensive Care Unit (NICU) for several reasons. First, many NICU patients are exposed to antibiotics, both via maternal administration and postnatal prescription, affecting the colonization of the intestinal tract. Additionally, the use of medical devices such as feeding tubes increase the risk of pathogenic colonization of microbes.<sup><xref rid="cit0045" ref-type="bibr">45</xref></sup> Acid suppression medications, which are commonly utilized in the NICU, have been associated with considerable changes in the diversity of the microbiome in infants.<sup><xref rid="cit0046" ref-type="bibr">46</xref></sup> The longer the NICU stay, the additional risk of exposure to hospital-acquired pathogens that inhibit the ability of native bacterial species to colonize the intestine.<sup><xref rid="cit0045" ref-type="bibr">45</xref></sup> These exposures lead to increased bacterial instability and lowered microbial diversity, leaving the neonate vulnerable to intestinal disease.<sup><xref rid="cit0045" ref-type="bibr">45</xref>,<xref rid="cit0047" ref-type="bibr">47</xref></sup> Proteobacteria often dominate the infant&#8217;s gut microbiome during the first weeks of life in the NICU and are associated with NEC onset during the further course.<sup><xref rid="cit0048" ref-type="bibr">48</xref></sup> A clear understanding of iatrogenic factors predisposing infants to alterations in gut microbiota is necessary to minimize risk in the intensive care setting.</p></sec><sec disp-level="2" id="s0003-s2003"><title>Oxygen therapy</title><p>In preterm infants, oxygen therapy is a common treatment due to breathing difficulties or underdeveloped lungs &#8211; both hypoxia as well as hyperoxia, however, are associated with detrimental health risks.<sup><xref rid="cit0049" ref-type="bibr">49</xref></sup> Oxidative stress has been demonstrated to provoke &#8216;oxygen radical disease&#8217; including several disease manifestations, such as retinopathy of prematurity (ROP), bronchopulmonary dysplasia, or NEC.<sup><xref rid="cit0050" ref-type="bibr">50</xref></sup> Additionally, respiratory support in premature infants affects the microbiome, causing a relative abundance of aerobic and facultative anaerobic bacteria.<sup><xref rid="cit0051" ref-type="bibr">51</xref></sup></p><p>The Neonatal Oxygenation Prospective Meta-analysis (NeOProM) compared oxygen saturation target levels in randomized controlled trials (RCTs) including premature infants born&#8201;&lt;28&#8201;weeks&#8217; gestation.<sup><xref rid="cit0052" ref-type="bibr">52</xref></sup> Lower oxygen saturation (85&#8211;89%) was associated with increased death and risk of surgical NEC, while higher saturation (91&#8211;95%) reduced risk of ROP.<sup><xref rid="cit0052" ref-type="bibr">52</xref></sup> Furthermore, lower cerebral tissue oxygenation throughout NICU admission was demonstrated in infants with NEC compared to infants without NEC.<sup><xref rid="cit0053" ref-type="bibr">53</xref></sup></p></sec><sec disp-level="2" id="s0003-s2004"><title>Analgesia and sedation</title><p>Many infants in the NICU require medications for analgesia and sedation. Opioid exposure can cause changes in gut development, gut motility and variability in the microbiome. Suggested mechanisms for this in animal models include alterations in bacterial metabolites, including short-chain fatty acids, bile acids, and bacterial diversity.<sup><xref rid="cit0054" ref-type="bibr">54</xref></sup> Evidence is limited on the use of sedative medication in the intensive care setting as a risk factor for NEC. Sedation-associated complications including mechanical ventilation, feeding delays, or hemodynamic changes, may indirectly affect NEC. Prenatal opioid exposure causing neonatal abstinence syndrome has been proposed as a risk factor for NEC in infants with late gestational age onset NEC (born&#8201;&gt;35&#8201;weeks).<sup><xref rid="cit0055" ref-type="bibr">55</xref></sup></p><p>The French prospective population-based study EPIPAGE2 analyzed NICU-associated treatment strategies during the first postnatal week in infants born at&#8201;&lt;32&#8201;weeks&#8217; gestation and their association with NEC.<sup><xref rid="cit0056" ref-type="bibr">56</xref></sup> Adjusted strong risk factors for NEC were hemodynamic failure requiring volume resuscitation, reduced gut motility, and anesthesia by sevoflurane for catheter insertion.<sup><xref rid="cit0056" ref-type="bibr">56</xref></sup> Sedation with morphine, fentanyl, or Sufentanil, however, showed no increased or even a reduced NEC risk.<sup><xref rid="cit0056" ref-type="bibr">56</xref></sup></p></sec><sec disp-level="2" id="s0003-s2005"><title>Mode of delivery</title><p>Mode of delivery impacts transfer of maternal microbiota to the fetus and thus influences microbiome diversity in the neonate. Vertical transfer is a phenomenon which describes the passing of maternal vaginal microbiota to the fetus as the child descends through the birth canal.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> For neonates born via Cesarean section, horizontal transfer is the term used to describe the delivery of bacteria to the neonate via skin-to-skin contact with other individuals in the environment.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> With vertical transfer of vaginal delivery, infants have a microbiota characterized by high levels of <italic toggle="yes">Lactobacillus, Bifidobacterium</italic>, <italic toggle="yes">Prevotella</italic>, and <italic toggle="yes">Bacteroides</italic>, which are members of the phyla Firmicutes, Actinobacteria, and Bacteroidetes.<sup><xref rid="cit0057" ref-type="bibr">57</xref>,<xref rid="cit0058" ref-type="bibr">58</xref></sup> Neonates born via Cesarean section have an intestinal microbiota with higher composition of <italic toggle="yes">Staphylococcus, Corynebacteria</italic>, and <italic toggle="yes">Propionibacterium</italic>, with low levels of <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Bacteroides</italic>.<sup><xref rid="cit0057" ref-type="bibr">57</xref>,<xref rid="cit0058" ref-type="bibr">58</xref></sup> Studies have found protective effects correlated with the <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Lactobacillus</italic> genera typically found in gut microbiota of vaginally delivered neonates.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> In contrast, the <italic toggle="yes">Staphylococcus</italic>-rich and <italic toggle="yes">Bifidobacterium</italic>-poor microbiome of neonates born via C-section have pathogenic potential.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> The variation in composition of microbiomes dependent upon method of delivery also corresponds to decreased bacterial diversity in infants delivered via C-section.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> Vaginal dysbiosis with a decrease in vaginal lactobacilli and higher proportions of anaerobes, however, can potentially increase NEC risk also after vaginal delivery. Current evidence shows contradictory results concerning the impact of mode of delivery on NEC onset. Prospective studies focusing on the distinct characterization of the infant&#8217;s and mother&#8217;s microbiome are necessary to identify potential associations.</p></sec><sec disp-level="2" id="s0003-s2006"><title>Neonatal diet</title><p>Feeding protocols are an essential component of neonatal care, especially for premature infants and those admitted to the NICU. While oral enteral autonomy is the goal, not all infants achieve this.<sup><xref rid="cit0059" ref-type="bibr">59</xref></sup> Feeding methods must be adjusted to account for neurologic and gastrointestinal function. The neurologic underdevelopment in infants born before 34&#8201;weeks gestational age creates difficulty coordinating reflexive responses such as sucking, swallowing, and breathing.<sup><xref rid="cit0060" ref-type="bibr">60</xref></sup> Because of this, premature infants are typically gavage fed, as the tube supplies nutrients directly to the stomach.<sup><xref rid="cit0060" ref-type="bibr">60</xref></sup> The susceptibility to gastrointestinal diseases such as necrotizing enterocolitis has been associated with variations in feeding methods of neonates.</p><p>Breast milk provides oligosaccharides, metabolites, and other factors, such as heat-sensitive proteins, that regulate microbiome development.<sup><xref rid="cit0061" ref-type="bibr">61&#8211;64</xref></sup> A randomized controlled trial demonstrated that mother&#8217;s own milk is the primary factor in shaping the preterm infant gut microbiome, with an even bigger impact on weight gain or microbial diversity than milk fortifier type or antibiotic exposure.<sup><xref rid="cit0065" ref-type="bibr">65</xref></sup> Specifically, oligosaccharides can promote colonization of the gut barrier with <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Bacteroides</italic>, which have protective effects on neonatal health and development.<sup><xref rid="cit0057" ref-type="bibr">57</xref></sup> Increased growth of beneficial bacteria, due to their more efficient utilization of oligosaccharides compared to potential pathogens, has been demonstrated.<sup><xref rid="cit0066" ref-type="bibr">66</xref></sup> Cesarean section influences lactogenesis and delays the establishment of breastfeeding. Donor milk is an effective substitute often used for preterm infants that do not have access to maternal milk. However, donor milk and formula ultimately lack some nutrients, bioactive compounds, or live cells that have shorter shelf life or bioavailability.<sup><xref rid="cit0067" ref-type="bibr">67</xref></sup> These perturbations in microbiome development due to feeding modality and source can leave the infant susceptible to NEC. The relationship between feeding methods and microbiome composition is integral to epithelial barrier homeostasis and neonatal health. Recent research suggests that breast milk microbiota may affect the infant&#8217;s microbiome and NEC risk.<sup><xref rid="cit0068" ref-type="bibr">68</xref></sup> Further studies investigating the differences in bioactive components of breast milk between mothers and the association with disease development are necessary to gain insight on NEC risk factors due to feeding modality, and to understand why human milk is protective, yet not eliminating NEC onset.</p><p>Parenteral nutrition (PN) is a standard practice for nutritional support of preterm infants when full enteral feeds cannot be safely provided.<sup><xref rid="cit0069" ref-type="bibr">69</xref></sup> Many studies have shown that PN dramatically changes the microbiome, causing a low abundance of <italic toggle="yes">Firmicutes</italic> and a high prevalence of <italic toggle="yes">Bacteroidetes</italic> and <italic toggle="yes">Proteobacteria</italic> phylum, as well as <italic toggle="yes">Actinobacteria</italic> phylum and <italic toggle="yes">Akkermansia muciniphila</italic>.<sup><xref rid="cit0070" ref-type="bibr">70</xref></sup>
<italic toggle="yes">Bacteroidetes</italic> phylum can cause intestinal inflammation and increase intestinal permeability, driving a bacterial flux across the mucosa and resulting in a cytokine-mediated hepatocellular injury. Additionally, PN increases the growth of opportunistic pathogens including <italic toggle="yes">E. coli, Salmonella, Yersinia, Helicobacter</italic> and <italic toggle="yes">Vibrio</italic>, and decreases the abundance of commensal microbials such as <italic toggle="yes">Bacteroides fragilis</italic>.<sup><xref rid="cit0070" ref-type="bibr">70</xref></sup> These changes also affect gastrointestinal immunity, making the infant more susceptible to intestinal diseases such as NEC.</p></sec><sec disp-level="2" id="s0003-s2007"><title>Antibiotic exposure</title><p>Maternal and neonatal antibiotic exposure commonly stems from both preventative and treatment-based measures perinatally. Due to an increased risk of infection, a range of 30&#8211;50% of premature neonates receive some form of antibiotic therapy.<sup><xref rid="cit0071" ref-type="bibr">71</xref></sup> Additionally, more than 40% of pregnant individuals receive an antibiotic prior to delivery.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Preventative antibiotic treatment is typically targeting Group B <italic toggle="yes">Streptococcus</italic> (GBS), or it is administered as a preoperative infectious prophylaxis before C-section.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Neonatal GBS has been known to cause sepsis and meningitis, while maternal GBS has created complications such as chorioamnionitis, sepsis, and endometritis.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Approximately 10&#8211;30% of pregnant individuals have GBS present in the vagina or rectum, thus intrapartum antibiotic prophylaxis lowers the rate of transfer to the fetus during vaginal delivery.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Early onset disease (EOD) GBS is characterized as occurring within the first week following birth and has a higher incidence in neonates whose mother was GBS positive.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Since a GBS culture takes 48&#8211;72&#8201;hours to produce results, it is not feasible to determine maternal GBS status during labor and thus recommendations state GBS testing should occur around 35&#8211;37 gestational weeks.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Therefore, GBS status is unavailable for premature infants. As a result, intrapartum antibiotic prophylaxis is standard of care to reduce the risk of development of EOD GBS.<sup><xref rid="cit0072" ref-type="bibr">72</xref></sup> Due to the common use of maternal and fetal antibiotic therapy during various stages of pregnancy, it is important to consider the effects of this regimen on the intestinal health of the neonate, specifically regarding the composition of their gut microbiome.</p><p>Both prenatal and postnatal antibiotic exposures have been associated with potential effects on the formation and diversity of gut microbiota in neonates. In a study conducted on newborn mice, the impact of antibiotic treatment on gut microbiome diversity, intestinal barrier function and permeability, and susceptibility to NEC-modeled injury was examined.<sup><xref rid="cit0071" ref-type="bibr">71</xref></sup> The results showed a reduced microbiota species diversity in mice treated with antibiotic therapy as compared to controls.<sup><xref rid="cit0071" ref-type="bibr">71</xref></sup> Additionally, when pups treated with antibiotics were exposed to pathogenic bacteria (induced experimental NEC), increased permeability and inflammatory cytokines in the intestine were identified.<sup><xref rid="cit0071" ref-type="bibr">71</xref></sup> Another study was performed to compare the gut microbiome of 30 premature infants with that of 176 term infants using meconium and stool samples collected over the first six weeks of life.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup> Abundance of beneficial <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Bacteroides</italic> were significantly lower following newborn antibiotic therapy in preterm versus term infants, with even lower levels in very premature children born at&#8201;&lt;28&#8201;weeks&#8217; gestation.<sup><xref rid="cit0006" ref-type="bibr">6</xref></sup> These results suggested that early gestational age is associated with reduced bacterial diversity and potential pathogenic growth. Dantas <italic toggle="yes">et al</italic>. demonstrated that meropenem, ticarcillin-clavulanate, and cefotaxime were associated with decreased species richness and all antibiotic treatments enriched the presence of resistance genes and multidrug resistant organisms.<sup><xref rid="cit0073" ref-type="bibr">73</xref></sup> Furthermore, the duration of antibiotic therapy has a significant impact on dysbiosis, which can increase risk of NEC. A higher risk of dysbiosis with reduction of Bifidobacteria and Staphylococci has been demonstrated in preterm infants undergoing antibiotic courses for seven days.<sup><xref rid="cit0040" ref-type="bibr">40</xref></sup></p></sec><sec disp-level="2" id="s0003-s2008"><title>Probiotics</title><p>Probiotic administration in neonates is a controversial topic. Several randomized controlled trials and cohort studies have reported that the supplementation of probiotics can reduce the incidence of NEC. Probiotic strains, specifically belonging to the bacterial genus <italic toggle="yes">Bifidobacterium</italic>, can significantly shift the composition of the preterm microbiome, accelerating maturation and facilitating health-promoting changes in immune and metabolic parameters.<sup><xref rid="cit0036" ref-type="bibr">36</xref></sup> A meta-analysis including 73 studies explored the association between probiotics and NEC and found that overall incidence and mortality were decreased.<sup><xref rid="cit0074" ref-type="bibr">74</xref></sup> The results need to be interpreted cautiously. There is significant variation in probiotics available, with differences in species, dose and time of administration. We currently lack a pharmaceutical-grade probiotic product that has been studied in very low birth weight infants. Further standardization, surveillance and research need to be done to ensure safe and effective use in preterm infants.</p></sec></sec><sec disp-level="1" id="s0004"><title>Premature gut barrier dysfunction</title><p>In addition to intestinal immaturity and delayed gastrointestinal development in the premature gut, several mechanisms contribute to barrier dysfunction.<sup><xref rid="cit0075" ref-type="bibr">75</xref>,<xref rid="cit0076" ref-type="bibr">76</xref></sup> Here, we present an overview of the key mechanisms implicated in gut barrier dysfunction in the premature infant and their role in NEC.</p><sec disp-level="2" id="s0004-s2001"><title>Toll-like receptor 4</title><p>TLR4 is a bacterial receptor that plays a pivotal role in the innate immune response by detecting lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria. TLR4 is expressed on the cell surface of IECs and macrophages and is associated with crypt stress and proinflammatory immune cell recruitment.<sup><xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0077" ref-type="bibr">77</xref></sup> Overactivation of TLR4&#160;has been implicated in NEC, triggering a proinflammatory immune response and apoptosis in intestinal crypts.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0077" ref-type="bibr">77</xref>,<xref rid="cit0078" ref-type="bibr">78</xref></sup> Bacterial peptidoglycan and its fragments are sensed through pattern recognition receptors (PRR), with TLR4 being the most common receptor on IECs, macrophages, and dendritic cells.<sup><xref rid="cit0079" ref-type="bibr">79</xref></sup> Highly expressed during the prenatal period, TLR4 supports gut development and intestinal stem cell proliferation.<sup><xref rid="cit0079" ref-type="bibr">79</xref></sup> Its expression physiologically decreases after birth and may induce an overshooting proinflammatory response ultimately leading to bowel necrosis and sepsis in preterm infants.<sup><xref rid="cit0079" ref-type="bibr">79</xref></sup> The TLR4/Nuclear Factor kappa B (NF-&#954;B) signaling pathway has been proposed as a crucial mechanism for hypoxia-induced barrier damage, bacterial translocation, and sepsis.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> The proinflammatory immune response is accompanied by dysfunctional epithelial cell interactions, including dysregulation of the cadherin-catenin-cytoskeleton interface.<sup><xref rid="cit0080" ref-type="bibr">80</xref></sup> It also has a role as part of the ROCK1&#8211;TLR4&#8211;NF-&#954;B signaling pathway in macrophages and induces a more proinflammatory macrophage phenotype by increasing glycolysis.<sup><xref rid="cit0081" ref-type="bibr">81</xref>,<xref rid="cit0082" ref-type="bibr">82</xref></sup> Overall, TLR4&#160;has a critical role in intestinal inflammation and the pathogenesis of NEC.</p></sec><sec disp-level="2" id="s0004-s2002"><title>Mucin</title><p>Impairment in the mucosal layer plays a key role in barrier dysfunction. The mucosal barrier is the first line of defense that protects the host against bacterial translocation and entry of other potential pathogens.<sup><xref rid="cit0083" ref-type="bibr">83</xref></sup> Mucus consists of secreted as well as transmembrane mucins and is produced by the goblet cells.<sup><xref rid="cit0083" ref-type="bibr">83</xref></sup> It functions as a physical barrier as well as a protective lubricant that prevents epithelial damage.<sup><xref rid="cit0083" ref-type="bibr">83</xref></sup> Mucins can provide an energy source for bacteria capable of degrading it and an imbalance between biosynthesis and degradation can change the microbiome and induce inflammation.<sup><xref rid="cit0083" ref-type="bibr">83</xref></sup> Expression of mucin genes (<italic toggle="yes">MUC</italic>) is affected in NEC.<sup><xref rid="cit0083" ref-type="bibr">83</xref>,<xref rid="cit0084" ref-type="bibr">84</xref></sup> In goblet cells of preterm infants with NEC, expression of transmembrane MUC1 as well as of secreted MUC2 is impaired compared to non-NEC preterm children.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> MUC1 plays a role in lubrication, protecting cells, maintaining stickiness, identifying cells and maintaining the functional integrity of epithelial cells. It can also participate in intracellular signal transduction and immune regulation. When the intestinal epithelium is damaged, there is a large release of MUC1 to repair in the intestinal mucosa. The impaired function and secretion of MUC1 in preterm infants with NEC is thought to play an important role in the pathogenesis.</p></sec><sec disp-level="2" id="s0004-s2003"><title>Intestinal alkaline phosphatase</title><p>Intestinal alkaline phosphatase (IAP) is a mucosal defense enzyme that is produced specifically by enterocytes, exerting antibacterial and anti-inflammatory effects.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> IAP deficiency is associated with dysbiosis and increased gut barrier permeability, pointing out the importance of IAP to maintain gut barrier function.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> IAP can detoxify lipopolysaccharides (LPS) and prevent bacterial adherence and growth.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> It exerts anti-inflammatory effects in a TLR4-dependent manner and plays a significant role in NEC.<sup><xref rid="cit0085" ref-type="bibr">85&#8211;87</xref></sup> In rat pups with NEC, IAP expression was decreased and enteral IAP administration reduced intestinal injury caused by LPS.<sup><xref rid="cit0087" ref-type="bibr">87</xref></sup> IAP is also believed to promote intestinal bacterial diversity thanks to its ability to dephosphorylate nucleotide triphosphates. A reduction of IAP leads to decreased bacterial growth.<sup><xref rid="cit0032" ref-type="bibr">32</xref></sup> Furthermore, IAP decreases intestinal permeability. Studies with IAP knock out mice have shown significant downregulation of TJ proteins and increased intestinal permeability.<sup><xref rid="cit0032" ref-type="bibr">32</xref></sup> Overall, IAP is involved in dysbiosis, intestinal integrity, and perfusion and plays a role in several molecular mechanisms that contribute to NEC development.</p></sec><sec disp-level="2" id="s0004-s2004"><title>GLUT</title><p>The GLUT family of membrane proteins is responsible for monosaccharide transport across the intestinal barrier and consists of 14 different isoforms encoded by the solute carrier transporter 2 (<italic toggle="yes">SLC2</italic>) gene.<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> The GLUT2 and GLUT5&#160;have been shown to play a role in intestinal inflammation and microbial regulation in colitis rat models.<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> While <italic toggle="yes">GLUT5</italic> gene expression was downregulated in small intestine of rats with iodacetamide-induced colitis,<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> the intestinal-specific deletion of <italic toggle="yes">GLUT2</italic> in rats led to improvement of inflammation and to an increase in commensal bacteria.<sup><xref rid="cit0088" ref-type="bibr">88</xref></sup> In preterm children with NEC, small intestinal GLUT2 and GLUT5 protein expressions were decreased.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup></p></sec><sec disp-level="2" id="s0004-s2005"><title>Paneth cell-specific lysozyme</title><p>Most of the functions of Paneth cells are related the products they secrete such as antibacterial products, lysozyme, and a variety of antimicrobial peptides that aid in blocking the invasion of pathogenic microorganisms. Paneth cells are the primary source of lysozyme, a &#946;-1,4-N -acetylmuramoylhydrolase which targets bacterial cell walls. Paneth cells and Paneth cell-specific lysozyme gene expression are lowest in preterm infants, increased in full-term infants, and highest in adults.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> Lysozyme can be found in saliva, tears, and breast milk, and can therefore be transmitted vertically from mother to infant.<sup><xref rid="cit0089" ref-type="bibr">89</xref></sup> Lysozyme achieves bactericidal action by processing the bacterial cell wall and destroying the permeability of the bacterial cell membrane.<sup><xref rid="cit0090" ref-type="bibr">90</xref></sup> Without Paneth cells, lysozyme is reduced, and the host is unable to resist invasion by foreign pathogens. In NEC, when intestinal mucosal inflammation occurs, Paneth cells are stimulated to release a large amount of lysozyme to kill harmful pathogens and mediate homeostasis of the intestinal flora.<sup><xref rid="cit0091" ref-type="bibr">91</xref></sup> Due to diminished numbers of Paneth cells in preterm infants, the lysozyme response is not strong enough to prevent intestinal injury and is only measurable during the recovery phase.<sup><xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0089" ref-type="bibr">89</xref></sup> Additionally, murine studies showed reduced Paneth cell numbers were associated with dysbiosis involving overgrowth of gram-negative bacteria, such as <italic toggle="yes">E. coli</italic>.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> In summary, the premature infant is exposed to pathogenic factors before the developing Paneth cells can reach their full protective potential, leaving neonates susceptible to disruption of the intestinal tract and NEC.</p></sec><sec disp-level="2" id="s0004-s2006"><title>Peptide defensin alpha 6 (DEFA6)</title><p>Another antimicrobial molecule produced by Paneth cells is the peptide defensin alpha (DEFA6).<sup><xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0092" ref-type="bibr">92</xref></sup> DEFA6 mRNA levels are detectable at 13.5&#8211;17&#8201;weeks of gestation in the small intestine but have very little expression until the middle of the third trimester.<sup><xref rid="cit0093" ref-type="bibr">93</xref></sup> Enteric DEFA6 mRNA levels are significantly lower in newborns than in adults, along with fewer numbers of Paneth cells in the crypts. Additionally, surgical specimens of infants with NEC showed lower DEFA6 levels than controls.<sup><xref rid="cit0004" ref-type="bibr">4</xref></sup> Sufficient <italic toggle="yes">DEFA</italic> expression seems to contribute to inflammatory homeostasis and may be important in understanding NEC pathogenesis.</p></sec></sec><sec disp-level="1" id="s0005"><title>The role of microbial metabolites in the premature gut barrier</title><p>The gut microbiota metabolizes dietary components into active metabolites that directly regulate human physiology including gut barrier function (<xref rid="t0002" ref-type="table">Table 2</xref>). Studies elucidating the functional activities of metabolites on gut barrier integrity and immune function in inflammatory diseases are expanding. While these studies have been performed in adults in diseases such as IBD, colitis, colon cancer and more, we believe their role would be similarly beneficial in the premature gut, and potentially consequential in the pathogenesis of NEC.<table-wrap position="float" id="t0002" orientation="portrait"><label>Table 2.</label><caption><p>Molecular characteristics of necrotizing enterocolitis (NEC), potential therapeutic targets and associated microbial metabolites.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">NEC characteristics</th><th align="center" colspan="1" rowspan="1">Potential causes of intestinal barrier dysfunction in NEC</th><th align="center" colspan="1" rowspan="1">Potential therapeutic targets/pathways</th><th align="center" colspan="1" rowspan="1">Associated microbial metabolites</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Microbial dysbiosis</td><td align="left" colspan="1" rowspan="1">IBD: more facultative anaerobe Enterobacteriaceae, decreased <italic toggle="yes">Faecalibacterium prausnitzii</italic> (specific SCFA production capacity), pathogenic bacteria (excessive, harming butyrate production) such as <italic toggle="yes">C. perfringens</italic>, <italic toggle="yes">C. difficile</italic>, <italic toggle="yes">C. paraputrificum</italic>, <italic toggle="yes">C. butyricum</italic>, and <italic toggle="yes">K. pneumoniae</italic></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0001"><list-item><p>High butyrate production (<italic toggle="yes">C. butyricum</italic>) increasing gene expression of inducible nitric oxide synthase (<italic toggle="yes">iNOS</italic>), nitric oxide production and TNF&#945; expression in IEC (NF-&#954;B pathway, histone acetylation<sup><xref rid="cit0094" ref-type="bibr">94</xref></sup>)</p></list-item><list-item><p>Activation of caspase-1 via the inflammasome (Salmonella typhimurium, Pseudomonas aeruginosa), pro-IL1&#946; &#8594; IL-1&#946;<sup><xref rid="cit0048" ref-type="bibr">48</xref></sup></p></list-item><list-item><p>Lactic acid production (<italic toggle="yes">L. rhamnosus, L. reuteri</italic>) decreasing the Th17/Treg ratio via JAK-STAT signaling pathway<sup><xref rid="cit0095" ref-type="bibr">95</xref></sup></p></list-item><list-item><p>Promotion of monocyte apoptosis (<italic toggle="yes">L. rhamnosus</italic>) via mitochondrial pathway and anti-inflammatory TGF-1&#946; induction<sup><xref rid="cit0096" ref-type="bibr">96</xref></sup></p></list-item></list></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0002"><list-item><p>SCFAs (i.e. acetate, propionate, butyrate)</p></list-item><list-item><p>Lactate</p></list-item><list-item><p>Linoleate metabolites</p></list-item></list></td></tr><tr><td align="left" colspan="1" rowspan="1">Intestinal barrier permeability</td><td align="left" colspan="1" rowspan="1">Dysregulation of cell junction protein expression leading to instability</td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0003"><list-item><p>ROCK1 (E-cadherin)</p></list-item><list-item><p>c-Myc-dependent mechanism (E-cadherin)</p></list-item></list></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0004"><list-item><p>SCFAs (butyrate)</p></list-item></list></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Dysregulation of tight junction gene expression (claudin, ZO-1, occludin)</td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0005"><list-item><p>Upregulation of gene expression by FOXO3 (ZO-1/2, occludin, claudin)</p></list-item><list-item><p>AMP-activated protein kinase (AMPK) (TJ assembly of ZO-1, occludin)</p></list-item><list-item><p>Occludin phosphorylation and localization, Rac1-dependent mechanism</p></list-item><list-item><p>AhR-Nrf2 pathway</p></list-item><list-item><p>PPAR&#947;, NF-&#954;B</p></list-item><list-item><p>FXR</p></list-item></list></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0006"><list-item><p>SCFA</p></list-item><list-item><p>polyamines</p></list-item><list-item><p>Polyphenolic derivatives</p></list-item><list-item><p>CLA</p></list-item><list-item><p>Bile acids (CDCA, DCA)</p></list-item></list></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Reduced mucus production (decreased mucin gene expression)</td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0007"><list-item><p><italic toggle="yes">MUC1</italic> (MAPK signaling pathway)</p></list-item><list-item><p><italic toggle="yes">MUC2</italic> (MAPK signaling pathway)</p></list-item><list-item><p><italic toggle="yes">MUC3</italic> (histone deacetylase (HDAC) pathway)</p></list-item><list-item><p><italic toggle="yes">MUC4</italic><sup><xref rid="cit0097" ref-type="bibr">97</xref></sup></p></list-item></list></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0008"><list-item><p>SCFAs (butyrate)</p></list-item><list-item><p>Indole derivatives</p></list-item></list></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Decreased IEC proliferation</td><td align="left" colspan="1" rowspan="1">TGR5 receptor, cAMP-PKA-CREB signaling pathway<sup><xref rid="cit0098" ref-type="bibr">98</xref></sup></td><td align="left" colspan="1" rowspan="1">Bile acids</td></tr><tr><td align="left" colspan="1" rowspan="1">Proinflammatory cytokine production</td><td align="left" colspan="1" rowspan="1">M1-like macrophage polarization, metabolic reprogramming;<break/>Proinflammatory cytokine production in enterocytes</td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0009"><list-item><p>PI3K signaling pathway,</p></list-item></list><break/>ROCK1&#8211;TLR4&#8211;NF-&#954;B signaling pathway
<list list-type="bullet" id="list_0010"><list-item><p>PPAR&#945;</p></list-item><list-item><p>Type 1 IFN pathway</p></list-item><list-item><p>HIF-1&#945;-dependent gene expression via histone acetylation<sup><xref rid="cit0099" ref-type="bibr">99</xref></sup></p></list-item><list-item><p>PTPN2-dependent pathway<sup><xref rid="cit0100" ref-type="bibr">100</xref></sup></p></list-item></list></td><td align="left" colspan="1" rowspan="1"><list list-type="bullet" id="list_0011"><list-item><p>SCFAs</p></list-item><list-item><p>CLA</p></list-item><list-item><p>Tricarboxylic acid (TCA) metabolites (i.e. citrate, L-malic acid, oxaloacetate, succinate, itaconate)</p></list-item><list-item><p>Polyamines (spermidine)</p></list-item></list></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Proinflammatory cytokine production in CD4+ and CD8+ T cells</td><td align="left" colspan="1" rowspan="1">PPAR&#947;/NF-&#954;B pathway</td><td align="left" colspan="1" rowspan="1">CLA</td></tr><tr><td align="left" colspan="1" rowspan="1">Oxidative stress</td><td align="left" colspan="1" rowspan="1">Increased ER stress in vascular endothelial cells</td><td align="left" colspan="1" rowspan="1">ROCK1</td><td align="left" colspan="1" rowspan="1">SCFAs</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Heavy metal contamination in oral feeds (e. g. inorganic arsenic)</td><td align="left" colspan="1" rowspan="1">AhR-Nrf2 pathway<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0101" ref-type="bibr">101</xref></sup></td><td align="left" colspan="1" rowspan="1">UroA</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p>IBD&#8201;=&#8201;Inflammatory Bowel Disease; SCFA&#8201;=&#8201;Short-chain Fatty Acids; iNOS&#8201;=&#8201;inducible Nitric Oxide Synthase; NF-&#954;B&#8201;=&#8201;Nuclear Factor kappa-B; IL&#8201;=&#8201;Interleukin; JAK&#8201;=&#8201;Janus Kinase; STAT&#8201;=&#8201;Signal Transducers and Activators of Transcription; TGF&#8201;=&#8201;Transforming Growth Factor; ROCK1&#8201;=&#8201;Rho-associated coiled-coil-containing protein kinase 1; c-Myc&#8201;=&#8201;Cellular Myelocytomatosis oncogene; ZO&#8201;=&#8201;Zonula occludens; FOXO3&#8201;=&#8201;Forkhead box O3; PPAR&#8201;=&#8201;Peroxisome Proliferator-activated Receptor; AhR-Nrf2&#8201;=&#8201;Aryl hydrocarbon Receptor &#8211; NF-E2 p45-related factor 2; FXR&#8201;=&#8201;Farnesoid X Receptor; CLA&#8201;=&#8201;Conjugated Linoleic Acid; CDCA&#8201;=&#8201;Chenodeoxycholic acid; DCA&#8201;=&#8201;Deoxycholic acid; MUC&#8201;=&#8201;Mucin; TGR5&#8201;=&#8201;Takeda G protein-coupled receptor 5; PKA&#8201;=&#8201;Protein Kinase A; CREB&#8201;=&#8201;cAMP Response Element-Binding Protein; PI3K&#8201;=&#8201;Phosphoinositide 3-Kinase; TLR4&#8201;=&#8201;Toll-like receptor 4; IFN&#8201;=&#8201;Interferon; PTPN2&#8201;=&#8201;Protein Tyrosine Phosphatase Non-receptor type 2; HIF-1&#945;&#8201;=&#8201;Hypoxia-inducible factor 1-alpha;UroA&#8201;=&#8201;Urolithin A.</p></fn></table-wrap-foot></table-wrap></p><sec disp-level="2" id="s0005-s2001"><title>Short-chain fatty acids (SCFAs)</title><p>SCFAs are considered a subtype of dietary microbial metabolites, as they are produced following fermentation of dietary fiber and undigested carbohydrates by <italic toggle="yes">Bifidobacterium</italic>, <italic toggle="yes">Lactobacillus</italic>, <italic toggle="yes">Enterococcus</italic> and <italic toggle="yes">Bacteroides</italic>.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0102" ref-type="bibr">102</xref></sup> In preterm infants with NEC, the microbiome predominantly consisted of the phyla Proteobacteria and Firmicutes, with small populations of Bacteroides and Actinobacteria of&#8201;&lt;2%. Overall, the abundance of anti-inflammatory SCFA producing bacteria in NEC patients was found to be reduced.<sup><xref rid="cit0103" ref-type="bibr">103</xref>,<xref rid="cit0104" ref-type="bibr">104</xref></sup> In patients with IBD, microbiota show enrichment of certain bacterial species, such as facultative anaerobe Enterobacteriaceae, including adherent-invasive <italic toggle="yes">Escherichia coli</italic> in the terminal ileum and the loss of obligate anaerobic producers of SCFAs.<sup><xref rid="cit0015" ref-type="bibr">15</xref></sup> A commonly reported commensal bacterium with anti-inflammatory SCFA production capacities that is decreased in ileal Crohn&#8217;s disease is the clostridium <italic toggle="yes">Faecalibacterium prausnitzii</italic>.<sup><xref rid="cit0104" ref-type="bibr">104</xref></sup> A reduction of this major member of Firmicutes is associated with postoperative and endoscopic disease recurrence at 6&#8201;months.<sup><xref rid="cit0104" ref-type="bibr">104</xref>,<xref rid="cit0105" ref-type="bibr">105</xref></sup> In NEC, Firmicutes was one of the dominant phyla, however, the relative proportion of beneficial gram-positive organisms, such as <italic toggle="yes">Faecalibacterium prausnitzii</italic>, was only found in a minority of cases.<sup><xref rid="cit0103" ref-type="bibr">103</xref></sup> In healthy adults <italic toggle="yes">Faecalibacterium prausnitzii</italic> makes up to 15% of the total fecal microbiota and is therefore representing one of the most abundant bacteria.<sup><xref rid="cit0106" ref-type="bibr">106</xref></sup></p><p>SCFAs affect diverse cell types via cell surface G-protein coupled receptors (GPRs), SCFA transporters, and several intracellular targets, inducing a variety of cell type-specific effects.<sup><xref rid="cit0107" ref-type="bibr">107</xref></sup> Three key metabolites classified as SCFAs are propionate, butyrate, and acetate, all of which play a role in immune cell differentiation and protection against foreign pathogens.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0077" ref-type="bibr">77</xref></sup> SCFAs derived from bacterial carbohydrate and amino acid fermentation, particularly butyrate, activate IAP gene expression and alter the luminal pH, further affecting its function.<sup><xref rid="cit0108" ref-type="bibr">108</xref>,<xref rid="cit0109" ref-type="bibr">109</xref></sup> Butyrate also has a significant impact on cellular metabolism and generally inhibits glucose metabolism in epithelial and immune cells. This has been shown by decreased <italic toggle="yes">GLUT1</italic> expression in colorectal cancer cells, which is associated with increased levels of butyrate inhibiting glucose metabolism.<sup><xref rid="cit0110" ref-type="bibr">110</xref></sup> Limited glucose metabolism enhances a more anti-inflammatory environment, particularly via anti-inflammatory polarization in macrophages (<xref rid="f0002" ref-type="fig">Figure 2</xref>). Furthermore, SCFAs are associated with increased MUC2 expression and may serve as an anti-inflammatory mediator preventing inflammation and cancer development<sup><xref rid="cit0111" ref-type="bibr">111</xref></sup> (<xref rid="f0002" ref-type="fig">Figure 2</xref>).
<fig position="float" id="f0002" fig-type="figure" orientation="portrait"><label>Figure 2.</label><caption><p>Microbial metabolites as multifaceted mediators in small intestinal barrier dysfunction.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KGMI_A_2551117_F0002_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KGMI_A_2551117_F0002_PB.jpg"/></alternatives><attrib>Small intestinal barrier integrity is balanced by a network of microbial metabolites that are mediators in every layer. These are examples of effects exerted by short-chain fatty acids (SCFA), lactate, conjugated fatty acids (CFA), and indole derivatives in mucus, epithelial and submucosal layers.</attrib><attrib>SCFA bind to G-Protein-Coupled Receptors (GPR41, GPR43) on enterocytes and inhibit proinflammatory cytokine expression via the NF-&#954;B pathway (i.e. TNF&#945;) as well as inflammasome activation and interleukin (IL)-1&#946; production. Additionally, SCFA increase tight junction gene expression (occludin, claudin, zonula occludens 1 and 2 (ZO-1/2). SCFA and lactate further regulate enterocyte regeneration and proliferation, partially through Forkhead box O3 (FOXO3). SCFA increase <italic toggle="yes">MUC2</italic> expression and therefore mucus production in goblet cells by inhibiting histone deacetylase (HDAC). In macrophages, SCFA additionally induce M2-like macrophage polarization via peroxisome proliferator-activated receptor alpha (PPAR&#945;).</attrib><attrib>Conjugated fatty acids (CFA) activate PPAR&#947; in macrophages and CD4+ T-cells.</attrib><attrib>The aryl hydrocarbon receptor (AhR) is activated by indole derivatives, such as urolithin A. AhR enhances barrier integrity by increasing tight junction expression (occludin, claudin, zonula occludens, ZO-1/2) in enterocytes.</attrib><attrib><italic toggle="yes">SCFA&#8201;=&#8201;Short-chain Fatty Acids; CFA&#8201;=&#8201;Conjugated Fatty Acids; ZO&#8201;=&#8201;Zonula Occludens; NF-&#954;B&#8201;=&#8201;Nuclear Factor kappa-B; TNF&#945;&#8201;=&#8201;Tumor Necrosis Factor alpha; IL&#8201;=&#8201;Interleukin; STAT3&#8201;=&#8201;Signal Transducer and Activator of Transcription 3; FOXO3&#8201;=&#8201;Forkhead box O3; MUC2&#8201;=&#8201;Mucin 2; HDAC&#8201;=&#8201;Histone Deacetylase; PPAR&#8201;=&#8201;Peroxisome Proliferator-activated Receptor; NLRP3&#8201;=&#8201;Nod-like Receptor Protein 3; AhR&#8201;=&#8201;Aryl hydrocarbon Receptor</italic></attrib></fig></p><p>In the infant&#8217;s gut, SCFAs are suspected to exert anti-inflammatory effects by altering DNA and histone methylation of proinflammatory genes<sup><xref rid="cit0102" ref-type="bibr">102</xref></sup> (<xref rid="f0002" ref-type="fig">Figure 2</xref>). Immunomodulatory effects are induced through inhibition of histone deacetylases and enhanced acetylation of signaling molecules, such as the serine/threonine kinase p70 S6 kinase.<sup><xref rid="cit0107" ref-type="bibr">107</xref></sup> Furthermore, SCFA-derived acetyl coenzyme A affects citric acid cycle catabolism and promotes mTOR activation, a central pathway regulating immunity, inflammation, and gut barrier integrity.<sup><xref rid="cit0112" ref-type="bibr">112</xref>,<xref rid="cit0113" ref-type="bibr">113</xref></sup> Butyrate can reduce inflammation via the development of T<sub>reg</sub> cells.<sup><xref rid="cit0104" ref-type="bibr">104</xref></sup> It specifically regulates intestinal permeability through activation of AMP-activated protein kinase (AMPK), which in turn induces assembly of TJs, such as ZO-1 and occludin, critical for barrier integrity.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Excessive luminal butyrate production by pathogenic bacteria, such as <italic toggle="yes">Clostridium perfringens</italic> (<italic toggle="yes">C. perfringens</italic>), <italic toggle="yes">C. difficile</italic>, <italic toggle="yes">C. paraputrificum</italic>, <italic toggle="yes">C. butyricum</italic>, and <italic toggle="yes">Klebsiella pneumoniae</italic> (<italic toggle="yes">K. pneumoniae</italic>), however, may reduce gut barrier integrity and may contribute to inflammation in infants with NEC.<sup><xref rid="cit0102" ref-type="bibr">102</xref></sup> This may be aggravated by poor gastrointestinal motility in preterm infants, which increases luminal lactose fermentation, resulting in increased butyric acid production.<sup><xref rid="cit0102" ref-type="bibr">102</xref></sup> In a NEC model using quails, high butyrate levels produced by <italic toggle="yes">C. butyricum</italic> enhances gene expression of inducible nitric oxide synthase (<italic toggle="yes">iNOS</italic>), which induces mucosal injury.<sup><xref rid="cit0114" ref-type="bibr">114</xref></sup></p><p>SCFAs also affect the Phosphoinositide 3-Kinase (PI3K) signaling pathway, which is an upstream activator of RhoA/Rho kinase 1 (ROCK1), a critical regulator of barrier function in NEC.<sup><xref rid="cit0080" ref-type="bibr">80</xref></sup> ROCK1 promotes inflammation in IBD by increasing endoplasmic reticulum (ER) stress in vascular endothelial cells and by provoking M1-like macrophage polarization.<sup><xref rid="cit0082" ref-type="bibr">82</xref></sup> In NEC, ROCK1 upregulation leads to increased intestinal permeability due to instability of the cell adhesion molecule E-cadherin.<sup><xref rid="cit0080" ref-type="bibr">80</xref></sup> Neonatal mice fed butyrate showed reduction in intestinal injury by inhibiting TLR signaling via Notch1.<sup><xref rid="cit0115" ref-type="bibr">115</xref></sup></p></sec><sec disp-level="2" id="s0005-s2002"><title>Tryptophan metabolism</title><p>Tryptophan is an amino acid found in diets rich in red meat, fish, egg, cheese, cruciferous vegetables and beans. Maternal breast milk, donor breast milk and formula all have tryptophan; however, maternal breast milk has the highest concentrations. Tryptophan is catabolized into indole by tryptophanase which is expressed by microbes such as <italic toggle="yes">Clostridium sporogenes</italic>. These indole derivatives are essential for cell-to-cell communication. Tryptophan is a key modulator of the neonatal microbiome as its indole metabolites have direct effects on immune cells and gut barrier permeability.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0116" ref-type="bibr">116</xref></sup> IEC expression of the rate-limiting enzyme in tryptophan metabolism, indoleamine 2,3-dioxygenase 1 (<italic toggle="yes">IDO1</italic>), has a significant impact on the metabolism of tryptophan by gut microbiota to generate indole metabolites.<sup><xref rid="cit0117" ref-type="bibr">117</xref></sup></p><p>Reduction of the tryptophan metabolites indoleacrylic acid and indole-3-lactic acid (ILA) is a feature in IBD and NEC.<sup><xref rid="cit0103" ref-type="bibr">103</xref>,<xref rid="cit0118" ref-type="bibr">118</xref>,<xref rid="cit0119" ref-type="bibr">119</xref></sup> Indoleacrylic acid is produced by commensal <italic toggle="yes">Peptostreptococcus</italic> spp. and ILA can be produced by Bifidobacteria.<sup><xref rid="cit0104" ref-type="bibr">104</xref>,<xref rid="cit0119" ref-type="bibr">119</xref></sup> Indole and indole-containing derivatives exert anti-inflammatory effects by activating the intracellular aryl hydrocarbon receptor (AHR) or pregnane X receptor (PXR), expressed in IEC and innate immune cells.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0101" ref-type="bibr">101</xref>,<xref rid="cit0116" ref-type="bibr">116</xref></sup> This induces immune cell maturation, increases TJ protein expression, and even reverses hypoxia-induced gut barrier dysfunction in mice.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In an IBD model using mice, anti-inflammatory host caspase recruitment domain family member 9 (<italic toggle="yes">CARD9</italic>) gene expression altered microbiome composition, decreased microbial tryptophan metabolism, and increased intestinal inflammation.<sup><xref rid="cit0120" ref-type="bibr">120</xref></sup>
<italic toggle="yes">Card9</italic><sup>&#8722;/&#8722;</sup> mice demonstrated reduced microbial tryptophan metabolism into AHR ligands, which increased intestinal inflammation.<sup><xref rid="cit0120" ref-type="bibr">120</xref></sup> In a human organoid and a primary human NEC cell line model, ILA reduced proinflammatory cytokine expression of IL-8 following an IL-1&#946; stimulus.<sup><xref rid="cit0119" ref-type="bibr">119</xref></sup></p><p>Furthermore, indole derivatives that stem from bacterial tryptophan metabolism can increase MUC2 expression and strengthen the intestinal barrier by upregulating tight junction proteins and inducing anti-inflammatory cytokine expression.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0111" ref-type="bibr">111</xref></sup> This is achieved by regulation of the AHR and pregnane X receptor (PXR), which makes them potential targets in IBD and carcinogenesis.<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0111" ref-type="bibr">111</xref></sup> A preventative approach has been reported in a NEC mouse model by AHR activation during pregnancy, which led to reduced TLR4 signaling independent of leucocyte activation.<sup><xref rid="cit0101" ref-type="bibr">101</xref></sup> Part of this mechanism shown in mice was AHR activation using indole-3-carbinol (I3C), which inhibited downstream pathways via NF-xB.<sup><xref rid="cit0101" ref-type="bibr">101</xref></sup> We therefore state that indole derivatives may represent promising therapeutic compounds in NEC and that further research should investigate their barrier strengthening effects, particularly through the AhR-dependent pathways.</p></sec><sec disp-level="2" id="s0005-s2003"><title>Bile acid metabolism</title><p>Bile acids are steroid-based molecules produced by the liver that aid in fat digestion, absorption, and gut microbiome regulation. Primary bile acids, such as cholic acid (CA) and chenodeoxycholic acid (CDCA), are synthesized in the liver from cholesterol. Secondary bile acids are modified by gut bacteria through dihydroxylation and deconjugation and include deoxycholic acid (DCA), ursodeoxycholic acid (UDCA) and lithocholic acid (LCA).<sup><xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0121" ref-type="bibr">121</xref></sup> The bacterial genera <italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Lactobacillus</italic>, and <italic toggle="yes">Bifidobacterium</italic> contain bile salt hydrolase necessary for secondary bile acid production.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> Additionally, gut bacteria can form further bile acid derivatives in the colon through dehydrogenation and epimerization reactions that may function as signaling molecules.<sup><xref rid="cit0123" ref-type="bibr">123</xref></sup> Bile acids exert complex metabolic effects through the two canonical receptors, the Farnesoid X Receptor (FXR) and Takeda G Protein-Coupled Receptor 5 (TGR5).<sup><xref rid="cit0124" ref-type="bibr">124</xref></sup> Apart from other noncanonical targets, these receptors and associated pathways have been studied in cardiometabolic, inflammatory, and neoplastic diseases.<sup><xref rid="cit0124" ref-type="bibr">124</xref></sup> FXR contributes to gut barrier integrity, decreases inflammation and oxidative stress, and functions as a tumor suppressor in colorectal cancer.<sup><xref rid="cit0125" ref-type="bibr">125</xref></sup></p><p>In patients with active IBD, defective bile acid metabolism led to deconjugation, transformation to secondary bile acids, and desulphation.<sup><xref rid="cit0126" ref-type="bibr">126</xref></sup> Primary bile acids, such CA and CDCA, were increased in patients with IBD, while the secondary bile acids LCA and DCA were decreased.<sup><xref rid="cit0127" ref-type="bibr">127</xref></sup> Due to the ongoing microbial colonization of the gut and immature liver function in premature infants, bile acid metabolism is significantly altered and accumulation of toxic bile acid metabolites may enhance intestinal injury in NEC.<sup><xref rid="cit0128" ref-type="bibr">128</xref>,<xref rid="cit0129" ref-type="bibr">129</xref></sup></p><p>Research investigating the molecular effects of bile acids on intestinal barrier function showed that CDCA and LCA had opposing effects on integrity of the intestinal epithelium in human T84 cells.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> CDCA decreased levels of occludin and thus led to increased gut barrier permeability.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> No changes in barrier function were observed with sole treatment with LCA, yet LCA was shown to decrease CDCA-induced barrier permeability when present together.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In mice receiving a high-fat diet to examine the effects on gut barrier function in relation to levels of the secondary bile acids DCA and UDCA, a DCA-supplemented feeding regimen increased gut barrier permeability as compared to controls.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Further studies using cell models showed that DCA and CDCA increased barrier permeability, but there were no significant changes with UDCA.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> DCA and CDCA influenced barrier integrity via autophosphorylation of endothelial growth factor, dephosphorylation of the occludin protein, and reorganization of the cellular TJs.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> The function of bile acids and their isoforms may play a central role in NEC and regulatory effects may vary depending on the specific bile acid isoform and the environment of the host. In an NEC rat model, ileal luminal bile acids were associated with ileal damage and levels positively correlated with disease incidence and severity.<sup><xref rid="cit0130" ref-type="bibr">130</xref></sup> Measured bile acid levels, however, did not distinguish between primary and secondary bile acids and their respective functions during NEC development.<sup><xref rid="cit0130" ref-type="bibr">130</xref></sup> In preterm infants with NEC, results on the composition of bile acids compared to healthy controls are inconclusive.<sup><xref rid="cit0122" ref-type="bibr">122</xref>,<xref rid="cit0131" ref-type="bibr">131</xref></sup> A higher coefficient of variation in total bile acid levels before NEC onset, however, has been postulated as a potential predictive clinical marker.<sup><xref rid="cit0131" ref-type="bibr">131</xref></sup></p><p>FXR activity, a nuclear bile acid receptor with a major role in bile acid metabolism, is reduced in patients with IBD and <italic toggle="yes">FXR</italic> gene expression has been found to be decreased in inflamed mucosa of the colon.<sup><xref rid="cit0125" ref-type="bibr">125</xref></sup> Recent evidence from a NEC rat model, however, showed that elevated FXR expression was associated with intestinal inflammation and ileal damage, suggesting an FXR-mediated mechanism specific for NEC.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> FXR is also a regulator of intestinal barrier integrity by mediating TJ composition in intestinal inflammation.<sup><xref rid="cit0132" ref-type="bibr">132</xref></sup> We therefore postulate that overexpression of FXR in NEC may provoke bacterial translocation through dysregulation of TJ synthesis, such as claudin-1, occludin, and ZO-1 expression.</p></sec><sec disp-level="2" id="s0005-s2004"><title>Conjugated fatty acids</title><p>Conjugated fatty acids are microbial metabolites produced by various intestinal bacteria to further regulate gut homeostasis by affecting gut barrier TJs.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> The intestinal bacteria <italic toggle="yes">Bifidobacterium, Enterobacter</italic>, and <italic toggle="yes">Lactobacillus</italic>, among others, produce conjugated fatty acids, such as conjugated linoleic acid (CLA), from dietary fats.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In a mouse colitis model using dextran sulfate sodium (DSS), treatment with CLA led to upregulation of the tight junction proteins ZO-1, occludin, claudin-3, and E-cadherin 1 as compared to controls, thereby enhancing gut barrier function.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In experimental IBD using mice, dietary CLA isomers decreased intestinal inflammation and prevented colorectal tumor formation in a Peroxisome proliferator-activated receptor gamma (PPAR&#947;)-dependent manner.<sup><xref rid="cit0133" ref-type="bibr">133</xref></sup> In patients with Crohn&#8217;s disease, CLA suppressed proinflammatory cytokine production in CD4+ and CD8+ T cell subsets.<sup><xref rid="cit0134" ref-type="bibr">134</xref></sup> A similar mechanism has been reported in NEC, with CLA exerting anti-inflammatory effects via upregulation of PPAR&#947; and therefore prevention of NF&#954;B pathway activation.<sup><xref rid="cit0135" ref-type="bibr">135</xref></sup> CLA is also a potent activator of other PPARs, such as PPAR&#945;, which have a major role in cellular metabolism and macrophage polarization.<sup><xref rid="cit0136" ref-type="bibr">136</xref></sup> Therefore, conjugated fatty acids may be key immunomodulatory targets in NEC by reducing proinflammatory cytokine production and cell recruitment of leukocytes via the PPAR&#947;/NF&#954;B pathway.</p></sec><sec disp-level="2" id="s0005-s2005"><title>Polyamines</title><p>Polyamines are small, positively charged organic molecules essential for cell growth, gene regulation, gut homeostasis, and immune function. Three main forms of polyamines are putrescine, spermidine and spermine.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> The individual roles of polyamines in intestinal diseases, are yet to be identified. Polyamines are produced by a wide variety of bacteria, such as <italic toggle="yes">Escherichia coli</italic> or <italic toggle="yes">Pseudomonas</italic> species, through decarboxylation of precursor amino acids directly into polyamines or other intermediates.<sup><xref rid="cit0138" ref-type="bibr">138</xref></sup>
<italic toggle="yes">Escherichia coli</italic> colonization in germ-free mice led to an increase in IEC polyamine levels in colonocytes and accelerated epithelial renewal.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> Furthermore, bacterium-derived putrescine was associated with a higher proportion of colonic anti-inflammatory macrophages, suggesting an immune-modulating role of polyamines in inflammatory disease.<sup><xref rid="cit0137" ref-type="bibr">137</xref></sup> Spermidine exerted anti-inflammatory and barrier-protective effects through macrophages and IECs in a protein tyrosine phosphatase non-receptor type 2 (PTPN2) dependent manner.<sup><xref rid="cit0100" ref-type="bibr">100</xref></sup> Furthermore, polyamine depletion in IECs was associated with lower expression of the cell-to-cell adhesion protein E-cadherin through a c-Myc-dependent mechanism, leading to increased gut barrier permeability.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> In patients with ulcerative colitis, genes related to polyamine metabolism have been identified and correlated as predictors for progression of the disease and potential therapeutic targets.<sup><xref rid="cit0139" ref-type="bibr">139</xref></sup> Additionally, polyamine-nanoparticles exerted anti-inflammatory effects in an ulcerative colitis mouse model.<sup><xref rid="cit0140" ref-type="bibr">140</xref></sup> The role of polyamines in NEC pathogenesis is currently poorly understood, but elevated levels of fecal cadaverine and putrescine concentrations in healthy premature infants may point toward a potential inflammatory role of polyamines in neonates.<sup><xref rid="cit0141" ref-type="bibr">141</xref></sup></p></sec><sec disp-level="2" id="s0005-s2006"><title>Polyphenolic derivatives</title><p>Polyphenols are naturally occurring plant-based antioxidants that are metabolized by beneficial genera, such as <italic toggle="yes">Bifidobacteriaceae</italic> and <italic toggle="yes">Lactobacillaceae</italic>.<sup><xref rid="cit0142" ref-type="bibr">142</xref></sup> Bioactive compounds derived from the metabolism of polyphenols influence gut health, inflammation, and oxidative stress. There are a wide variety of polyphenolic derivatives with diverse anti-inflammatory, antioxidant, metal chelation, and neuroprotective properties.<sup><xref rid="cit0143" ref-type="bibr">143</xref>,<xref rid="cit0144" ref-type="bibr">144</xref></sup> An important class of secondary polyphenolic metabolites produced from dietary ellagic acid are urolithins, with urolithin A (UroA) exerting an important regulatory role in intestinal inflammation and epithelial injury.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> A mouse model using mice fed with a polyphenol-rich diet following DSS treatment, including one rich in ellagic acids, demonstrated that UroA can alleviate colitis and improve gut barrier function in an IL-22 dependent manner.<sup><xref rid="cit0145" ref-type="bibr">145</xref></sup> Furthermore, a complex crosstalk between microbiome and macrophages has been identified in these mice. Implantation of bone-marrow-derived macrophages into macrophage-depleted colitis mice led to declining intestinal inflammation with decreased levels of TNF-&#945; and IL-1&#946;, and increased IL-10 levels in colonic tissue.<sup><xref rid="cit0145" ref-type="bibr">145</xref></sup> Apart from regulating cytokine expression, UroA showed beneficial effects on tight junction proteins and intestinal barrier function in mice.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Expression of claudin-4, ZO-1, and occludin tight junction proteins was increased in an AHR-Nrf2-dependent manner.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Additional exploration of the impact of UroA on gut function has been performed using colon epithelial T84 cells.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup> Cytotoxicity in T84 cells following treatment with inorganic arsenic was reduced when cells were simultaneously treated with UroA, with a significant decrease in formation of reactive oxygen species, lactate dehydrogenase activity, and intestinal barrier permeability.<sup><xref rid="cit0011" ref-type="bibr">11</xref></sup></p><p>The beneficial effects on the intestinal microbiome, cytokine profiles, tight junction proteins, and gut barrier function suggest a key role of microbial metabolites in NEC prevention and treatment. Preventive treatment had the largest impact on preterm neonate gut bacteria modulation and the development of a mature microbiome.<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup> A randomized controlled trial on microbiota administration routes in preterm infants showed that probiotic administration at the age of 7&#8201;days with <italic toggle="yes">Lactobacillus and Bifidobacterium genera</italic> sufficiently modulated gut microbiota.<sup><xref rid="cit0001" ref-type="bibr">1</xref></sup>
<italic toggle="yes">Bifidobacterium</italic> supplementation led to beneficial effects through SCFAs only when infants were simultaneously fed with human milk oligosaccharides (HMOs).<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup> These findings support the postulated NEC-preventive role of breast-feeding in preterm infants as bacterial HMO conversion is reduced by formula feeding.<sup><xref rid="cit0014" ref-type="bibr">14</xref></sup></p></sec></sec><sec disp-level="1" id="s0006"><title>Microbial composition and the possible impact on NEC pathogenesis and treatment</title><p>Inflammatory mechanisms described in intestinal pathologies, such as IBD or colorectal cancer, are mediated by microbial metabolites. Investigating overlaps in disease-related inflammatory pathways and cellular interactions helps to identify downstream differences in disease pathogeneses and therefore NEC-specific mechanisms. The microbiome orchestrates metabolome-related inflammation and gut barrier integrity, which makes microbial metabolites and microbiome composition a potential target in NEC pathogenesis and treatment. Potential metabolite-based therapeutic implications in NEC are given in <xref rid="t0003" ref-type="table">Table 3</xref>.<table-wrap position="float" id="t0003" orientation="portrait"><label>Table 3.</label><caption><p>Microbial metabolite therapeutic applications in NEC.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/><col width="1*" align="left" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Metabolite application</th><th align="center" colspan="1" rowspan="1">Author</th><th align="center" colspan="1" rowspan="1">Study subjects</th><th align="center" colspan="1" rowspan="1">Study intervention</th><th align="center" colspan="1" rowspan="1">Outcomes/Pathway/Target genes</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Increase in SCFA concentration</td><td align="left" colspan="1" rowspan="1">Yu et al.<sup><xref rid="cit0115" ref-type="bibr">115</xref></sup></td><td align="left" colspan="1" rowspan="1">DOL5 C57BL/6J (B6) pups</td><td align="left" colspan="1" rowspan="1">Neonatal mice fed sodium butyrate for 3&#8201;days showed decreased intestinal damage in NEC</td><td align="left" colspan="1" rowspan="1">TLR4, Notch1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Zhang et al.<sup><xref rid="cit0146" ref-type="bibr">146</xref></sup></td><td align="left" colspan="1" rowspan="1">Seven-day-old C57BL/6 mice</td><td align="left" colspan="1" rowspan="1">Mouse pups fed butyrate-containing formula milk</td><td align="left" colspan="1" rowspan="1">Fut2, MEK4-JNK signaling</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Gao et al.<sup><xref rid="cit0147" ref-type="bibr">147</xref></sup></td><td align="left" colspan="1" rowspan="1">3-day-old neonatal Sprague-Dawley rat pups</td><td align="left" colspan="1" rowspan="1">Rat pups fed sodium butyrate for 18&#8201;days post NEC induction</td><td align="left" colspan="1" rowspan="1">TLR4, NLRP3 inflammasome, NF-&#954;B signaling</td></tr><tr><td align="left" colspan="1" rowspan="1">Indole derivative administration</td><td align="left" colspan="1" rowspan="1">Nolan et al.<sup><xref rid="cit0148" ref-type="bibr">148</xref></sup></td><td align="left" colspan="1" rowspan="1">4-day-old neonatal mice</td><td align="left" colspan="1" rowspan="1">Mouse pups fed with I3C for 4&#8201;days post NEC induction</td><td align="left" colspan="1" rowspan="1">AhR, Cyp1a1</td></tr><tr><td align="left" colspan="1" rowspan="1">Targeting bile acid metabolism</td><td align="left" colspan="1" rowspan="1">S&#246;nmezg&#246;z et al.<sup><xref rid="cit0149" ref-type="bibr">149</xref></sup></td><td align="left" colspan="1" rowspan="1">Rat pups</td><td align="left" colspan="1" rowspan="1">Enteral administration of UDCA during NEC induction</td><td align="left" colspan="1" rowspan="1">Bax, caspase-3, platelet-activating factor, IFABP</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Calton et al.<sup><xref rid="cit0150" ref-type="bibr">150</xref></sup></td><td align="left" colspan="1" rowspan="1">Sprague-Dawley rat pups delivered 1 day before scheduled birth</td><td align="left" colspan="1" rowspan="1">Bile acid sequestration via cholestyramine in rat formula feeds containing <italic toggle="yes">C. scindens</italic> once per day</td><td align="left" colspan="1" rowspan="1">Apical sodium-dependent bile acid transporter (Asbt), intraenterocyte bile acid level</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Lai et al.<sup><xref rid="cit0151" ref-type="bibr">151</xref></sup></td><td align="left" colspan="1" rowspan="1">10-day-old KM mouse pups</td><td align="left" colspan="1" rowspan="1">Intraperitoneal injection of melatonin daily starting one day before NEC induction</td><td align="left" colspan="1" rowspan="1">SIRT1/FXR signaling axis</td></tr><tr><td align="left" colspan="1" rowspan="1">Maternal dietary intervention</td><td align="left" colspan="1" rowspan="1">Khalesi et al.<sup><xref rid="cit0152" ref-type="bibr">152</xref></sup></td><td align="left" colspan="1" rowspan="1">RCT in women with very low birth weight infants (<italic toggle="yes">n</italic>&#8201;=&#8201;120)</td><td align="left" colspan="1" rowspan="1">Maternal dairy-free diet for 14&#8201;days postpartum to evaluate NEC incidence in exclusively breastfeeding women with very low birth weight infants</td><td align="left" colspan="1" rowspan="1">NEC incidence</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Mariela Bernabe-Garc&#237;a et al.<sup><xref rid="cit0153" ref-type="bibr">153</xref></sup></td><td align="left" colspan="1" rowspan="1">RCT in preterm infants (<italic toggle="yes">n</italic>&#8201;=&#8201;225)</td><td align="left" colspan="1" rowspan="1">Enteral docosahexaenoic acid administration daily for 14&#8201;days from the first enteral feed after birth</td><td align="left" colspan="1" rowspan="1">NEC incidence</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Rumph et al.<sup><xref rid="cit0154" ref-type="bibr">154</xref></sup></td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Paternal fish oil supplementation during one cycle of spermatogenesis after 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure before conception in reproductive-age male mice</td><td align="left" colspan="1" rowspan="1">Microbiome modification (decreasing Firmicutes, increasing beneficial Negativicutes), formula-associate intestinal injury</td></tr><tr><td align="left" colspan="1" rowspan="1">Fecal Microbiota Transplant (FMT)</td><td align="left" colspan="1" rowspan="1">Wolski et al.<break/>ClinicalTrials.gov ID: <ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06333405">NCT06333405</ext-link><break/>Phase: Safety assessment (first-in-human)</td><td align="left" colspan="1" rowspan="1">Study ongoing<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;20)</td><td align="left" colspan="1" rowspan="1">Maternal third trimester donor fecal microbiota administered via rectal infusion to highrisk preterm infants (24&#8211;36&#8201;weeks gestation) within first 3&#8211;14&#8201;days after birth</td><td align="left" colspan="1" rowspan="1">NEC incidence</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Hui et al.<sup><xref rid="cit0155" ref-type="bibr">155</xref></sup></td><td align="left" colspan="1" rowspan="1">Crossbred piglets (Landrace&#8201;&#215;&#8201;Yorkshire&#8201;&#215;&#8201;Duroc) delivered at 90% gestation (106&#8201;days)</td><td align="left" colspan="1" rowspan="1">Piglets received either control saline, rectal FMT using ineffective, or FMT using effective donor stool. Piglets were followed for 4&#8201;days until necropsy and pathological gut evaluation.</td><td align="left" colspan="1" rowspan="1">Colonic gut microbiota composition, NEC</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">Prado et al.<sup><xref rid="cit0156" ref-type="bibr">156</xref></sup></td><td align="left" colspan="1" rowspan="1">One-day-old Wistar rats</td><td align="left" colspan="1" rowspan="1">Daily feeds of neonatal rats with feces from healthy adult rats starting 1 day before NEC induction and until necropsy 72&#8201;hours after NEC induction.</td><td align="left" colspan="1" rowspan="1">Proinflammatory and anti-inflammatory cytokines, IL-10, histological intestinal damage</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p>TLR4&#8201;=&#8201;Toll-Like Receptor 4; Notch1&#8201;=&#8201;Neurogenic Locus Notch Homolog Protein 1; Fut2&#8201;=&#8201;Fucosyltransferase 2; MEK4-JNK&#8201;=&#8201;Mitogen-Activated Protein Kinase Kinase 4 &#8211; c-Jun N-terminal Kinase; NLRP3&#8201;=&#8201;NOD-, LRR- and Pyrin Domain-Containing Protein 3; NF-&#954;B&#8201;=&#8201;Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells; I3C&#8201;=&#8201;Indole-3-Carbinol; AhR&#8201;=&#8201;Aryl Hydrocarbon Receptor; Cyp1a1&#8201;=&#8201;Cytochrome P450 1A1; UDCA&#8201;=&#8201;Ursodeoxycholic Acid; Bax&#8201;=&#8201;Bcl-2-Associated X Protein; IFABP&#8201;=&#8201;Intestinal Fatty Acid-Binding Protein; SIRT1&#8201;=&#8201;Sirtuin 1; FXR&#8201;=&#8201;Farnesoid X Receptor; IL-10&#8201;=&#8201;Interleukin 10; RCT&#8201;=&#8201;Randomized Controlled Trial</p></fn></table-wrap-foot></table-wrap></p><sec disp-level="2" id="s0006-s2001"><title>Microbial SCFA production and effects of SCFA on gut barrier function</title><p>Microbes that indirectly or directly produce SCFAs are reduced in NEC. Probiotic therapy for NEC prevention has been postulated as most effective when containing Bifidobacterium and Lactobacillus, both anaerobic bacteria producing SCFAs.<sup><xref rid="cit0157" ref-type="bibr">157</xref></sup></p><p>Diet and microbial composition are the main factors regulating SCFA production, with breast milk or dietary fiber content increasing SCFA concentrations.<sup><xref rid="cit0147" ref-type="bibr">147</xref></sup> Bacterial populations are balancing their community by metabolizing and providing certain SCFAs via cross-feeding, which promotes an anti-inflammatory environment.<sup><xref rid="cit0107" ref-type="bibr">107</xref>,<xref rid="cit0158" ref-type="bibr">158</xref></sup></p><p>Probiotic supplementation containing bacteria and yeasts that increase SCFA production, such as <italic toggle="yes">Bifidobacterium</italic>, <italic toggle="yes">Lactobacillus</italic>, and <italic toggle="yes">Saccharomyces</italic> genera, has been postulated to prevent NEC and decrease NEC-related mortality in preterm infants.<sup><xref rid="cit0159" ref-type="bibr">159</xref></sup> In mice, butyrate supplementation increased intestinal mucin and tight junction-related gene expression and decreased proinflammatory cytokines.<sup><xref rid="cit0147" ref-type="bibr">147</xref></sup> Thus, SCFA-promoting microbiota in preterm infants could improve gut barrier integrity and promote an anti-inflammatory environment, protecting against NEC. A first clinical trial investigating fecal microbiota transplantation (FMT) as a prophylaxis for NEC in preterm infants is currently pending (<ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT06333405">NCT06333405</ext-link>). Further studies are necessary to investigate the impact of SCFAs in the preterm gut and their role in NEC prevention and therapy.</p></sec><sec disp-level="2" id="s0006-s2002"><title>Bile acid-modifying microbiota and FXR-NLRP3 signaling</title><p>Certain bacteria, such as clostridia, can modify bile acids which enhanced bile-acid-related epithelial damage in an experimental NEC model using rats.<sup><xref rid="cit0150" ref-type="bibr">150</xref></sup> In this model, <italic toggle="yes">Clostridium scindens</italic> did not show NEC-promoting effects in the absence of bile acids, suggesting a particular role of bile acid-modifying microbiota in NEC pathology.<sup><xref rid="cit0150" ref-type="bibr">150</xref></sup>
<italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Lactobacillus</italic>, and <italic toggle="yes">Bifidobacterium</italic>, which are beneficial in NEC, contain bile salt hydrolase (BSH), an enzyme central in bile acid metabolism.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> In rats, BSH activity in <italic toggle="yes">B. fragilis</italic> was associated with reduced microbial dysbiosis and improved bile acid metabolism by inhibiting the FXR-NLRP3 signaling pathway.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> Therefore, <italic toggle="yes">B. fragilis</italic> has been proposed as a potential therapeutic in infants.<sup><xref rid="cit0122" ref-type="bibr">122</xref></sup> The role of bile acid-modifying bacteria in premature infants and their effects on NEC, however, are yet to be investigated.</p></sec><sec disp-level="2" id="s0006-s2003"><title>Tryptophan-metabolizing microbiota and indole-derivative crosstalk</title><p><italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Lactobacillus</italic>, <italic toggle="yes">Bifidobacterium</italic>, and certain Clostridium strains produce immunomodulatory and gut barrier protective indole derivatives.<sup><xref rid="cit0160" ref-type="bibr">160</xref></sup> Overall, more than 85 bacterial species express tryptophanase, which metabolizes dietary tryptophan resulting in indole production.<sup><xref rid="cit0161" ref-type="bibr">161</xref></sup> Particularly, <italic toggle="yes">Lactobacillus</italic> produces ILA-derived tryptophan, which induced growth of other tryptophan-metabolizing bacteria and subsequent production of other indole derivatives, such as IPA and IAA.<sup><xref rid="cit0162" ref-type="bibr">162</xref></sup> This ILA-mediated cross-feeding could reverse dysbiosis due to <italic toggle="yes">Citrobacter rodentium</italic> or DSS in mice.<sup><xref rid="cit0162" ref-type="bibr">162</xref></sup> Indoles reduce intestinal inflammation and improve gut barrier function, but also function as signaling molecules between bacteria. Depending on the concentration of the respective indole derivative, it affects formation of spores, maintenance of plasmids, drug insensitivity, or toxicity.<sup><xref rid="cit0163" ref-type="bibr">163</xref></sup> Tryptophan metabolism is complex and many bacterial species contribute either directly or indirectly by producing only certain types of indole derivatives, enhancing downstream reactions in tryptophan metabolism, or by promoting growth of other bacterial species that are involved in this multi-level crosstalk.<sup><xref rid="cit0163" ref-type="bibr">163</xref></sup> Probiotic therapy with <italic toggle="yes">Bifidobacteria</italic> to produce ILA from tryptophan in breast milk has been proposed as a potential therapeutic strategy in preterm infants with NEC.<sup><xref rid="cit0119" ref-type="bibr">119</xref></sup> Clinical trials are necessary to investigate the therapeutic role of certain bacteria that are involved in indole production in premature infants with NEC.</p></sec><sec disp-level="2" id="s0006-s2004"><title>Lactate and linolenic acid</title><p>An imbalance of lactate-producing bacteria, such as <italic toggle="yes">Lactobacillus</italic>, <italic toggle="yes">Streptococcus</italic>, or <italic toggle="yes">Bifidobacterium</italic>, and lactate-metabolizing microbiota, such as <italic toggle="yes">Bacteroidetes</italic> and <italic toggle="yes">Firmicutes</italic> phyla, can lead to lactate accumulation.<sup><xref rid="cit0164" ref-type="bibr">164</xref></sup> Elevated lactate levels have been proposed as a potential cause of NEC in premature infants.<sup><xref rid="cit0164" ref-type="bibr">164</xref></sup> In contrast, Lactococcus lactis and Lactobacillus reuteri, both lactic acid-producing bacteria, have been demonstrated to be beneficial in NEC rabbit and NEC rat models.<sup><xref rid="cit0165" ref-type="bibr">165</xref>,<xref rid="cit0166" ref-type="bibr">166</xref></sup> These contrary findings may be caused by the dual role of lactate in gut barrier function, where balanced lactate levels enhance barrier function, while lactate accumulation can have destructive effects.<sup><xref rid="cit0102" ref-type="bibr">102</xref></sup> This suggests that a physiological balance of lactate-producing and lactate-utilizing microbes is necessary to achieve protective effects in infants with NEC. Further studies are needed to investigate the potential role of bacteria affecting lactate levels in NEC.</p></sec><sec disp-level="2" id="s0006-s2005"><title>Role of viruses and fungi in microbial composition</title><p>Nonbacterial microbiome constituents, such as viruses including bacteriophages and fungi, have been shown to affect microbial composition in preterm infants.<sup><xref rid="cit0167" ref-type="bibr">167</xref></sup> Like the gut microbiome, the gut virome varies between infants and undergoes dynamic changes during the first year of life.<sup><xref rid="cit0044" ref-type="bibr">44</xref>,<xref rid="cit0168" ref-type="bibr">168</xref></sup> Recent evidence also describes co-transmission of bacterial strains together with viral strains from mother to child.<sup><xref rid="cit0168" ref-type="bibr">168</xref></sup> Compared to the maternal gut virome, infant viromes include more active bacteriophage populations that decrease over time.<sup><xref rid="cit0168" ref-type="bibr">168</xref></sup> This might point toward a specific role for phage-bacteria interactions during the first weeks of life and therefore for NEC onset. In preterm infants with NEC, a relative abundance of the bacteriophage families <italic toggle="yes">Myoviridae</italic>, <italic toggle="yes">Podoviridae</italic> and <italic toggle="yes">Siphoviridae</italic> was found.<sup><xref rid="cit0044" ref-type="bibr">44</xref></sup> Furthermore, <italic toggle="yes">Escherichia</italic> and <italic toggle="yes">Streptococcus</italic> were proposed as relevant strains correlating with NEC-associated viral contigs.<sup><xref rid="cit0044" ref-type="bibr">44</xref></sup></p><p>The effect of the gut virome on NEC development is subject to current research yet still underexplored. Apart from FMT, fecal virome transplantation (FVT) or fecal filtrate transplantation (FFT, involving viruses, metabolites, and cell debris without bacteria) are gaining attention.<sup><xref rid="cit0169" ref-type="bibr">169</xref></sup> These methods could potentially be used as a therapeutic strategy in NEC by transplanting bacteriophages that enhance production of NEC-protective metabolites via phage-bacteria interaction in preterm infants.</p><p>Similar to the bacterial gut microbiome, eukaryotic fungi forming the mycobiome show reduced diversity in preterm infants compared to term infants.<sup><xref rid="cit0167" ref-type="bibr">167</xref></sup> In contrast to the bacterial populations, however, the mycobiome in healthy individuals in general progresses in complexity rather than in diversity and abundance.<sup><xref rid="cit0167" ref-type="bibr">167</xref></sup> Despite gut fungi representing only 0.01%&#8211;0.1% of the gut microbiome population, their cell size can be more than twice as large compared to bacteria, which makes fungi a significant part of the microbiome by size.<sup><xref rid="cit0170" ref-type="bibr">170</xref></sup> The term infants gut is mainly colonized by <italic toggle="yes">Saccharomyces</italic>, <italic toggle="yes">Candida</italic>, and <italic toggle="yes">Malassezia</italic> spp., while preterm infants&#8217; microbiomes are often dominated by <italic toggle="yes">Candida</italic> species.<sup><xref rid="cit0167" ref-type="bibr">167</xref></sup> Fungi&#8211;bacteria interactions can form microbiomes and exert immunomodulatory functions, making the mycobiome a potential target in NEC.<sup><xref rid="cit0167" ref-type="bibr">167</xref>,<xref rid="cit0170" ref-type="bibr">170</xref></sup> Fungal &#946;-glucan has recently been postulated as beneficial in murine NEC by reducing intestinal inflammation and improving gut barrier permeability, probably by inhibiting the TLR4-NF-&#954;B signaling pathway.<sup><xref rid="cit0146" ref-type="bibr">146</xref></sup></p></sec></sec><sec disp-level="1" id="s0007"><title>Barriers to progress</title><p>NEC is a rare, multifactorial disease which leads to heterogeneous study populations with variable diagnostic criteria and confounding factors.<sup><xref rid="cit0171" ref-type="bibr">171</xref></sup> Studies are therefore underpowered to draw strong conclusions and RCT design is challenging due to required sample size and standardized diagnostics and treatment despite multi-center collaborations. Furthermore, the collection of timely biospecimens in premature infants for mechanistic studies is technically demanding due to critical care priorities, poor gut motility, and extremely small blood volumes.<sup><xref rid="cit0172" ref-type="bibr">172</xref>,<xref rid="cit0173" ref-type="bibr">173</xref></sup> Particularly, measuring microbial metabolites within small volume samples is challenging, as samples have to be collected using standardized techniques at predefined time points and have to be stored and processed in a timely manner to minimize variation.<sup><xref rid="cit0174" ref-type="bibr">174</xref></sup> To link gut microbiome profiles with clinical intervention, alternative models of the neonatal gut are used &#8211; but cell line or animal models are particularly weak in resembling the preterm gut physiology, and mechanistic findings can often not be translated into the clinical setting.<sup><xref rid="cit0173" ref-type="bibr">173</xref></sup> Organoid models derived from LGR5-positive stem cells in intestinal crypts have been developed over recent years, as well as intestinal organoid cultures from embryonic stem cells and intestinal fragments from aborted fetuses.<sup><xref rid="cit0173" ref-type="bibr">173</xref></sup> These culture models, however, lack a gut microbiome, and their accuracy in resembling effects of microbial metabolites on the premature gut barrier has yet to be demonstrated.</p></sec><sec disp-level="1" id="s0008"><title>Conclusion</title><p>Dysfunction and dysregulation of the immature intestinal barrier in preterm infants have been demonstrated as risk factors for the development of NEC. Microbial metabolites exert central anti-inflammatory and immunomodulatory effects in various intestinal diseases, including <italic toggle="yes">C. difficile</italic> colitis, IBD, colorectal cancer, and NEC. The potential of microbiome-derived mediators, such as SCFAs or polyphenolic derivatives, to establish gut barrier integrity and reduce oxidative or inflammatory stress may provide promising target mechanisms in preterm infants with intestinal disease. To date, no preventative or therapeutic treatment targets have translated into clinical practice. The multifactorial pathogenesis of NEC, complexity of molecular interactions within the intestinal barrier, and necessity to utilize animal models for mechanistic studies are current challenges in NEC research. Microbial metabolites are widely demonstrated to regulate inflammatory processes and may play a key role in diagnosis, prevention, and early treatment of NEC. Further research on the impact of bacterial species, associated metabolites, and the intestinal inflammatory state is crucial to gain insight into preterm gut barrier dysfunction and NEC pathogenesis and in identifying microbial metabolites as effective treatment strategies.</p></sec></body><back><ack><title>Acknowledgments</title><p>Figures in this manuscript were created in <ext-link xlink:href="https://BioRender.com" ext-link-type="uri">https://BioRender.com</ext-link>.</p></ack><sec sec-type="COI-statement" disp-level="1" id="s0009"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec sec-type="data-availability" disp-level="1" id="s0010"><title>Data availability statement</title><p>The authors confirm that the data supporting the findings of this study are available within the article.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rahkola</surname><given-names>EN</given-names></string-name>, <string-name name-style="western"><surname>Rautava</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hiltunen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lahti</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Isolauri</surname><given-names>E.</given-names></string-name></person-group><article-title>The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial</article-title>. <source>Pediatr Res</source>. <year>2023</year>;<volume>94</volume>(<issue>4</issue>):<fpage>1480</fpage>&#8211;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-023-02560-y</pub-id>.<pub-id pub-id-type="pmid">37020105</pub-id><pub-id pub-id-type="pmcid">PMC10589095</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chelakkot</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ghim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ryu</surname><given-names>SH</given-names></string-name></person-group>. <article-title>Mechanisms regulating intestinal barrier integrity and its pathological implications</article-title>. <source>Exp Mol Med</source>. <year>2018</year>;<volume>50</volume>(<issue>8</issue>):<fpage>1</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s12276-018-0126-x</pub-id><pub-id pub-id-type="pmcid">PMC6095905</pub-id><pub-id pub-id-type="pmid">30115904</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Nov&#225;k</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gui</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>K</given-names></string-name></person-group>. <article-title>Enhancing intestinal barrier efficiency: a novel metabolic diseases therapy</article-title>. <source>Front Nutr</source>. <year>2023</year>;<volume>10</volume>:<fpage>1120168</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2023.1120168</pub-id>.<pub-id pub-id-type="pmid">36937361</pub-id><pub-id pub-id-type="pmcid">PMC10018175</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Demers-Mathieu</surname><given-names>V</given-names></string-name></person-group>. <article-title>The immature intestinal epithelial cells in preterm infants play a role in the necrotizing enterocolitis pathogenesis: a review</article-title>. <source>Health Sci Rev</source>. <year>2022</year>;<volume>4</volume>:<fpage>100033</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.hsr.2022.100033</pub-id>.</mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fawley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Koehler</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cabrera</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Fredrich</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hessner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Salzman</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gourlay</surname><given-names>D</given-names></string-name></person-group>. <article-title>Intestinal alkaline phosphatase deficiency leads to dysbiosis and bacterial translocation in the newborn intestine</article-title>. <source>J Surg Res</source>. <year>2017</year>;<volume>218</volume>:<fpage>35</fpage>&#8211;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jss.2017.03.049</pub-id>.<pub-id pub-id-type="pmid">28985873</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chernikova</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Madan</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Housman</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Zain-Ul-Abideen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lundgren</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Morrison</surname><given-names>HG</given-names></string-name>, <string-name name-style="western"><surname>Sogin</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Karagas</surname><given-names>MR</given-names></string-name>, et al</person-group>. <article-title>The premature infant gut microbiome during the first 6&#160;weeks of life differs based on gestational maturity at birth</article-title>. <source>Pediatr Res</source>. <year>2018</year>;<volume>84</volume>(<issue>1</issue>):<fpage>71</fpage>&#8211;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-018-0022-z</pub-id>.<pub-id pub-id-type="pmid">29795209</pub-id><pub-id pub-id-type="pmcid">PMC6082716</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Palleri</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Svenningsson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Markasz</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Engstrand Lilja</surname><given-names>H</given-names></string-name></person-group>. <article-title>The incidence of necrotizing enterocolitis and late-onset sepsis during the COVID-19 pandemic in Sweden: a population-based cohort study</article-title>. <source>Neonatology</source>. <year>2024</year>;<volume>121</volume>(<issue>3</issue>):<fpage>336</fpage>&#8211;<lpage>341</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000536570</pub-id>.<pub-id pub-id-type="pmid">38442693</pub-id><pub-id pub-id-type="pmcid">PMC11152026</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Neu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>WA</given-names></string-name></person-group>. <article-title>Necrotizing enterocolitis</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>364</volume>(<issue>3</issue>):<fpage>255</fpage>&#8211;<lpage>264</lpage>.<pub-id pub-id-type="pmid">21247316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1005408</pub-id><pub-id pub-id-type="pmcid">PMC3628622</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Flahive</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schlegel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mezoff</surname><given-names>EA</given-names></string-name></person-group>. <article-title>Necrotizing enterocolitis: updates on morbidity and mortality outcomes</article-title>. <source>J Pediatr</source>. <year>2020</year>;<volume>220</volume>:<fpage>7</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpeds.2019.12.035</pub-id>.<pub-id pub-id-type="pmid">31955884</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mortensen</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Bohr</surname><given-names>SSR</given-names></string-name>, <string-name name-style="western"><surname>Krog</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>B&#248;tker</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Kapousidou</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Saaby</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hatzakis</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>M&#248;rck Nielsen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>R&#248;nholt</surname><given-names>S</given-names></string-name></person-group>. <article-title>Neonatal intestinal mucus barrier changes in response to maturity, inflammation, and sodium decanoate supplementation</article-title>. <source>Sci Rep</source>. <year>2024</year>;<volume>14</volume>(<issue>1</issue>):<fpage>7665</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-58356-5</pub-id>.<pub-id pub-id-type="pmid">38561398</pub-id><pub-id pub-id-type="pmcid">PMC10985073</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Whitley</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Haribabu</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Jala</surname><given-names>VR</given-names></string-name></person-group>. <article-title>Regulation of intestinal barrier function by microbial metabolites</article-title>. <source>Cell Mol Gastroenterol Hepatol</source>. <year>2021</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1463</fpage>&#8211;<lpage>1482</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcmgh.2021.02.007</pub-id>.<pub-id pub-id-type="pmid">33610769</pub-id><pub-id pub-id-type="pmcid">PMC8025057</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singh</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chandrashekharappa</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bodduluri</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Baby</surname><given-names>BV</given-names></string-name>, <string-name name-style="western"><surname>Hegde</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kotla</surname><given-names>NG</given-names></string-name>, <string-name name-style="western"><surname>Hiwale</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Saiyed</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Vijay-Kumar</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>89</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-018-07859-7</pub-id>.<pub-id pub-id-type="pmid">30626868</pub-id><pub-id pub-id-type="pmcid">PMC6327034</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gasaly</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>de Vos</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hermoso</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<fpage>658354</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.658354</pub-id>.<pub-id pub-id-type="pmid">34122415</pub-id><pub-id pub-id-type="pmcid">PMC8187770</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Neumann</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Mahnert</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kumpitsch</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kiu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Dalby</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Kujawska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Madl</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kurath-Koller</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Urlesberger</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Resch</surname><given-names>B</given-names></string-name>, et al</person-group>. <article-title>Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestine</article-title>. <source>Nat Commun</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<fpage>1349</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-36825-1</pub-id>.<pub-id pub-id-type="pmid">36906612</pub-id><pub-id pub-id-type="pmcid">PMC10008552</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Danne</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Skerniskyte</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Marteyn</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sokol</surname><given-names>H</given-names></string-name></person-group>. <article-title>Neutrophils: from IBD to the gut microbiota</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2024</year>;<volume>21</volume>(<issue>3</issue>):<fpage>184</fpage>&#8211;<lpage>197</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41575-023-00871-3</pub-id>.<pub-id pub-id-type="pmid">38110547</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Indrio</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Neu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pettoello-Mantovani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Marchese</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Martini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Salatto</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Aceti</surname><given-names>A</given-names></string-name></person-group>. <article-title>Development of the gastrointestinal tract in newborns as a challenge for an appropriate nutrition: a narrative review</article-title>. <source>Nutrients</source>. <year>2022</year>;<volume>14</volume>(<issue>7</issue>):<fpage>1405</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14071405</pub-id>.<pub-id pub-id-type="pmid">35406018</pub-id><pub-id pub-id-type="pmcid">PMC9002905</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Neu</surname><given-names>J</given-names></string-name></person-group>. <article-title>Gastrointestinal development and meeting the nutritional needs of premature infants</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>(<issue>2</issue>):<fpage>629S</fpage>&#8211;<lpage>634S</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/85.2.629S</pub-id>.<pub-id pub-id-type="pmid">17284768</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vancamelbeke</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vermeire</surname><given-names>S</given-names></string-name></person-group>. <article-title>The intestinal barrier: a fundamental role in health and disease</article-title>. <source>Expert Rev Gastroenterol Hepatol</source>. <year>2017</year>;<volume>11</volume>(<issue>9</issue>):<fpage>821</fpage>&#8211;<lpage>834</lpage>. doi: <pub-id pub-id-type="doi">10.1080/17474124.2017.1343143</pub-id>.<pub-id pub-id-type="pmid">28650209</pub-id><pub-id pub-id-type="pmcid">PMC6104804</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yu</surname><given-names>QH</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Q</given-names></string-name></person-group>. <article-title>Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier</article-title>. <source>Cell Biol Int</source>. <year>2009</year>;<volume>33</volume>(<issue>1</issue>):<fpage>78</fpage>&#8211;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cellbi.2008.09.007</pub-id>.<pub-id pub-id-type="pmid">18938254</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Frazer</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Good</surname><given-names>M</given-names></string-name></person-group>. <article-title>Intestinal epithelium in early life</article-title>. <source>Mucosal Immunol</source>. <year>2022</year>;<volume>15</volume>(<issue>6</issue>):<fpage>1181</fpage>&#8211;<lpage>1187</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41385-022-00579-8</pub-id>.<pub-id pub-id-type="pmid">36380094</pub-id><pub-id pub-id-type="pmcid">PMC10329854</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Halpern</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Denning</surname><given-names>PW</given-names></string-name></person-group>. <article-title>The role of intestinal epithelial barrier function in the development of NEC</article-title>. <source>Tissue Barriers</source>. <year>2015</year>;<volume>3</volume>(<issue>1&#8211;2</issue>):<fpage>e1000707</fpage>. doi: <pub-id pub-id-type="doi">10.1080/21688370.2014.1000707</pub-id>.<pub-id pub-id-type="pmid">25927016</pub-id><pub-id pub-id-type="pmcid">PMC4389790</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fawkner-Corbett</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Antanaviciute</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Parikh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Jagielowicz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ger&#243;s</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Gupta</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ashley</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Khamis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fowler</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Morrissey</surname><given-names>E</given-names></string-name>, et al</person-group>. <article-title>Spatiotemporal analysis of human intestinal development at single-cell resolution</article-title>. <source>Cell</source>. <year>2021</year>;<volume>184</volume>(<issue>3</issue>):<fpage>810</fpage>&#8211;<lpage>826.e23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2020.12.016</pub-id>.<pub-id pub-id-type="pmid">33406409</pub-id><pub-id pub-id-type="pmcid">PMC7864098</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sternini</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Anselmi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rozengurt</surname><given-names>E</given-names></string-name></person-group>. <article-title>Enteroendocrine cells: a site of &#8216;taste&#8217; in gastrointestinal chemosensing</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source>. <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>73</fpage>&#8211;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MED.0b013e3282f43a73</pub-id>.<pub-id pub-id-type="pmid">18185066</pub-id><pub-id pub-id-type="pmcid">PMC2943060</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Paneth cell development in the neonatal gut: pathway regulation, development, and relevance to necrotizing enterocolitis</article-title>. <source>Front Cell Dev Biol</source>. <year>2023</year>;<volume>11</volume>:<fpage>1184159</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2023.1184159</pub-id>.<pub-id pub-id-type="pmid">37266449</pub-id><pub-id pub-id-type="pmcid">PMC10231676</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lueschow</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>McElroy</surname><given-names>SJ</given-names></string-name></person-group>. <article-title>The Paneth cell: the curator and defender of the immature small intestine</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>587</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.00587</pub-id>.<pub-id pub-id-type="pmid">32308658</pub-id><pub-id pub-id-type="pmcid">PMC7145889</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hunter</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Upperman</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Ford</surname><given-names>HR</given-names></string-name>, <string-name name-style="western"><surname>Camerini</surname><given-names>V</given-names></string-name></person-group>. <article-title>Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC)</article-title>. <source>Pediatr Res</source>. <year>2008</year>;<volume>63</volume>(<issue>2</issue>):<fpage>117</fpage>&#8211;<lpage>123</lpage>. doi: <pub-id pub-id-type="doi">10.1203/PDR.0b013e31815ed64c</pub-id>.<pub-id pub-id-type="pmid">18091350</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saitou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Furuse</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sasaki</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Schulzke</surname><given-names>J-D</given-names></string-name>, <string-name name-style="western"><surname>Fromm</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Takano</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Noda</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tsukita</surname><given-names>S</given-names></string-name></person-group>. <article-title>Complex phenotype of mice lacking occludin, a component of tight junction strands</article-title>. <source>Mol Biol Cell</source>. <year>2000</year>;<volume>11</volume>(<issue>12</issue>):<fpage>4131</fpage>&#8211;<lpage>4142</lpage>. doi: <pub-id pub-id-type="doi">10.1091/mbc.11.12.4131</pub-id>.<pub-id pub-id-type="pmid">11102513</pub-id><pub-id pub-id-type="pmcid">PMC15062</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kuo</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Odenwald</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Zuo</surname><given-names>L</given-names></string-name></person-group>. <article-title>Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival</article-title>. <source>Ann N Y Acad Sci</source>. <year>2022</year>;<volume>1514</volume>(<issue>1</issue>):<fpage>21</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1111/nyas.14798</pub-id>.<pub-id pub-id-type="pmid">35580994</pub-id><pub-id pub-id-type="pmcid">PMC9427709</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gunzel</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>AS</given-names></string-name></person-group>. <article-title>Claudins and the modulation of tight junction permeability</article-title>. <source>Physiol Rev</source>. <year>2013</year>;<volume>93</volume>(<issue>2</issue>):<fpage>525</fpage>&#8211;<lpage>569</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.00019.2012</pub-id>.<pub-id pub-id-type="pmid">23589827</pub-id><pub-id pub-id-type="pmcid">PMC3768107</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name></person-group>. <article-title>Mucins and tight junctions are severely altered in necrotizing enterocolitis neonates</article-title>. <source>Am J Perinatol</source>. <year>2021</year>;<volume>38</volume>(<issue>11</issue>):<fpage>1174</fpage>&#8211;<lpage>1180</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0040-1710558</pub-id>.<pub-id pub-id-type="pmid">32446259</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hosfield</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Shelley</surname><given-names>WC</given-names></string-name>, <string-name name-style="western"><surname>Mesfin</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Brokaw</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Manohar</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pecoraro</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Markel</surname><given-names>TA</given-names></string-name></person-group>. <article-title>Age disparities in intestinal stem cell quantities: a possible explanation for preterm infant susceptibility to necrotizing enterocolitis</article-title>. <source>Pediatr Surg Int</source>. <year>2022</year>;<volume>38</volume>(<issue>12</issue>):<fpage>1971</fpage>&#8211;<lpage>1979</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00383-022-05257-1</pub-id>.<pub-id pub-id-type="pmid">36208323</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martins</surname><given-names>RDS</given-names></string-name>, <string-name name-style="western"><surname>Kooi</surname><given-names>EMW</given-names></string-name>, <string-name name-style="western"><surname>Poelstra</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hulscher</surname><given-names>JBF</given-names></string-name></person-group>. <article-title>The role of intestinal alkaline phosphatase in the development of necrotizing enterocolitis</article-title>. <source>Early Hum Dev</source>. <year>2023</year>;<volume>183</volume>:<fpage>105797</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2023.105797</pub-id>.<pub-id pub-id-type="pmid">37300991</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buonpane</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ares</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Schlegel</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liebe</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Experimental modeling of necrotizing enterocolitis in human infant intestinal enteroids</article-title>. <source>J Invest Surg</source>. <year>2022</year>;<volume>35</volume>(<issue>1</issue>):<fpage>111</fpage>&#8211;<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.1080/08941939.2020.1829755</pub-id>.<pub-id pub-id-type="pmid">33100066</pub-id><pub-id pub-id-type="pmcid">PMC8840553</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bein</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Eventov-Friedman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Arbell</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schwartz</surname><given-names>B</given-names></string-name></person-group>. <article-title>Intestinal tight junctions are severely altered in NEC preterm neonates</article-title>. <source>Pediatr Neonatol</source>. <year>2018</year>;<volume>59</volume>(<issue>5</issue>):<fpage>464</fpage>&#8211;<lpage>473</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pedneo.2017.11.018</pub-id>.<pub-id pub-id-type="pmid">29276042</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Golubkova</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Development of the neonatal intestinal barrier, microbiome, and susceptibility to NEC</article-title>. <source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1247</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11051247</pub-id>.<pub-id pub-id-type="pmid">37317221</pub-id><pub-id pub-id-type="pmcid">PMC10221463</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mercer</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Arrieta</surname><given-names>MC</given-names></string-name></person-group>. <article-title>Probiotics to improve the gut microbiome in premature infants: are we there yet?</article-title><source>Gut Microbes</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>2201160</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2023.2201160</pub-id>.<pub-id pub-id-type="pmid">37122152</pub-id><pub-id pub-id-type="pmcid">PMC10153018</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Collado</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Rautava</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aakko</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Isolauri</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Salminen</surname><given-names>S</given-names></string-name></person-group>. <article-title>Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>23129</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep23129</pub-id>.<pub-id pub-id-type="pmid">27001291</pub-id><pub-id pub-id-type="pmcid">PMC4802384</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Claud</surname><given-names>EC</given-names></string-name></person-group>. <article-title>Necrotizing enterocolitis pathophysiology: how microbiome data alter our understanding</article-title>. <source>Clin Perinatol</source>. <year>2019</year>;<volume>46</volume>(<issue>1</issue>):<fpage>29</fpage>&#8211;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clp.2018.10.003</pub-id>.<pub-id pub-id-type="pmid">30771817</pub-id><pub-id pub-id-type="pmcid">PMC6816463</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Warner</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Deych</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hall-Moore</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Weinstock</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Sodergren</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Shaikh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Linneman</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Hamvas</surname><given-names>A</given-names></string-name>, et al</person-group>. <article-title>Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10031</issue>):<fpage>1928</fpage>&#8211;<lpage>1936</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00081-7</pub-id>.<pub-id pub-id-type="pmid">26969089</pub-id><pub-id pub-id-type="pmcid">PMC5553277</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Beck</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Masi</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Vatanen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Lamb</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Coxhead</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Butler</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Marsland</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Embleton</surname><given-names>ND</given-names></string-name>, et al</person-group>. <article-title>Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants</article-title>. <source>Nat Microbiol</source>. <year>2022</year>;<volume>7</volume>(<issue>10</issue>):<fpage>1525</fpage>&#8211;<lpage>1535</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-022-01213-w</pub-id>.<pub-id pub-id-type="pmid">36163498</pub-id><pub-id pub-id-type="pmcid">PMC9519454</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stewart</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Embleton</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Marrs</surname><given-names>ECL</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>DP</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Abdulkadir</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Skeath</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Petrosino</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Perry</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Berrington</surname><given-names>JE</given-names></string-name>, et al</person-group>. <article-title>Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease</article-title>. <source>Microbiome</source>. <year>2016</year>;<volume>4</volume>(<issue>1</issue>):<fpage>67</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40168-016-0216-8</pub-id>.<pub-id pub-id-type="pmid">28034304</pub-id><pub-id pub-id-type="pmcid">PMC5200962</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kiu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Shaw</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Sim</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Acuna-Gonzalez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Price</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Bedwell</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dreger</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Fowler</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Cornwell</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pickard</surname><given-names>D</given-names></string-name>, et al</person-group>. <article-title>Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strains</article-title>. <source>Nat Microbiol</source>. <year>2023</year>;<volume>8</volume>(<issue>6</issue>):<fpage>1160</fpage>&#8211;<lpage>1175</lpage>.<pub-id pub-id-type="pmid">37231089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41564-023-01385-z</pub-id><pub-id pub-id-type="pmcid">PMC10234813</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jarman</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Torres</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Stromberg</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sato</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Stack</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ladrillono</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pace</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jimenez</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Haselbeck</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Insel</surname><given-names>R</given-names></string-name>, et al</person-group>. <article-title>Bifidobacterium deficit in United States infants drives prevalent gut dysbiosis</article-title>. <source>Commun Biol</source>. <year>2025</year>;<volume>8</volume>(<issue>1</issue>):<fpage>867</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-025-08274-7</pub-id>.<pub-id pub-id-type="pmid">40555747</pub-id><pub-id pub-id-type="pmcid">PMC12187928</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kaelin</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hall-Moore</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Linneman</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Ndao</surname><given-names>IM</given-names></string-name>, <string-name name-style="western"><surname>Warner</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Tarr</surname><given-names>PI</given-names></string-name>, <string-name name-style="western"><surname>Holtz</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>ES</given-names></string-name></person-group>. <article-title>Longitudinal gut virome analysis identifies specific viral signatures that precede necrotizing enterocolitis onset in preterm infants</article-title>. <source>Nat Microbiol</source>. <year>2022</year>;<volume>7</volume>(<issue>5</issue>):<fpage>653</fpage>&#8211;<lpage>662</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-022-01096-x</pub-id>.<pub-id pub-id-type="pmid">35449461</pub-id><pub-id pub-id-type="pmcid">PMC9064801</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Snyder</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Bugs and the barrier: a review of the gut microbiome and intestinal barrier in necrotizing enterocolitis</article-title>. <source>Semin Pediatr Surg</source>. <year>2023</year>;<volume>32</volume>(<issue>3</issue>):<fpage>151310</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sempedsurg.2023.151310</pub-id>.<pub-id pub-id-type="pmid">37290337</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brusselaers</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Engstrand</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Engstrand Lilja</surname><given-names>H</given-names></string-name></person-group>. <article-title>Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort</article-title>. <source>Gut Pathog</source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>):<fpage>47</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13099-022-00518-9</pub-id>.<pub-id pub-id-type="pmid">36527125</pub-id><pub-id pub-id-type="pmcid">PMC9758939</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xiang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>K</given-names></string-name></person-group>. <article-title>Early gut microbiota intervention in premature infants: application perspectives</article-title>. <source>J Adv Res</source>. <year>2023</year>;<volume>51</volume>:<fpage>59</fpage>&#8211;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jare.2022.11.004</pub-id>.<pub-id pub-id-type="pmid">36372205</pub-id><pub-id pub-id-type="pmcid">PMC10491976</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Aziz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Prince</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name></person-group>. <article-title>Gut microbiome and necrotizing enterocolitis: understanding the connection to find a cure</article-title>. <source>Cell Host Microbe</source>. <year>2022</year>;<volume>30</volume>(<issue>5</issue>):<fpage>612</fpage>&#8211;<lpage>616</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2022.04.003</pub-id>.<pub-id pub-id-type="pmid">35550664</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martin</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Harijith</surname><given-names>AK</given-names></string-name></person-group>. <article-title>The twofold NICU challenge: avoiding hypoxia and hyperoxia</article-title>. <source>Pediatr Res</source>. <year>2021</year>;<volume>90</volume>(<issue>1</issue>):<fpage>4</fpage>&#8211;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-021-01518-2</pub-id>.<pub-id pub-id-type="pmid">33850293</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Perrone</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Manti</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Petrolini</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Dell&#8217;orto</surname><given-names>VG</given-names></string-name>, <string-name name-style="western"><surname>Boscarino</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Ceccotti</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bertini</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Buonocore</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Esposito</surname><given-names>SMR</given-names></string-name>, <string-name name-style="western"><surname>Gitto</surname><given-names>E</given-names></string-name></person-group>. <article-title>Oxygen for the newborn: friend or foe?</article-title><source>Children (Basel)</source>. <year>2023</year>;<volume>10</volume>(<issue>3</issue>):<fpage>579</fpage>. doi: <pub-id pub-id-type="doi">10.3390/children10030579</pub-id>.<pub-id pub-id-type="pmid">36980137</pub-id><pub-id pub-id-type="pmcid">PMC10047080</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hutchinson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wade</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Millar</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ansbro</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Stacey</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Costeloe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fleming</surname><given-names>P</given-names></string-name></person-group>. <article-title>Changes in the intestinal microbiome of the preterm baby associated with stopping non-invasive pressure support: a prospective cohort study</article-title>. <source>BMJ Paediatr Open</source>. <year>2024</year>;<volume>8</volume>(<issue>1</issue>):<fpage>e002675</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjpo-2024-002675</pub-id>.<pub-id pub-id-type="pmcid">PMC11459353</pub-id><pub-id pub-id-type="pmid">39362793</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Askie</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Darlow</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Finer</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Stenson</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Tarnow-Mordi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>PG</given-names></string-name>, <string-name name-style="western"><surname>Carlo</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Brocklehurst</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>LC</given-names></string-name>, et al</person-group>. <article-title>Association between oxygen saturation targeting and death or disability in extremely preterm infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration</article-title>. <source>JAMA</source>. <year>2018</year>;<volume>319</volume>(<issue>21</issue>):<fpage>2190</fpage>&#8211;<lpage>2201</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2018.5725</pub-id>.<pub-id pub-id-type="pmid">29872859</pub-id><pub-id pub-id-type="pmcid">PMC6583054</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Howarth</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Banerjee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Eaton</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Aladangady</surname><given-names>N</given-names></string-name></person-group>. <article-title>Cerebral oxygenation in preterm infants with necrotizing enterocolitis</article-title>. <source>Pediatrics</source>. <year>2020</year>;<volume>146</volume>(<issue>3</issue>). doi: <pub-id pub-id-type="doi">10.1542/peds.2020-0337</pub-id>.<pub-id pub-id-type="pmid">32848028</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McGlothen-Bell</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Groer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Brownell</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Gregory</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Crawford</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Francis</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lopez</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>McGrath</surname><given-names>JM</given-names></string-name></person-group>. <article-title>A scoping review of neonatal opioid withdrawal and the infant gut microbiome: does human milk optimize infant outcomes?</article-title><source>Adv Neonatal Care</source>. <year>2023</year>;<volume>23</volume>(<issue>3</issue>):<fpage>237</fpage>&#8211;<lpage>245</lpage>.<pub-id pub-id-type="pmid">36867674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ANC.0000000000001056</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Andrews</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Haas</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Loudin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Heyward</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Werthammer</surname><given-names>J</given-names></string-name></person-group>. <article-title>Necrotizing enterocolitis and its association with the neonatal abstinence syndrome</article-title>. <source>J Neonatal Perinatal Med</source>. <year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>81</fpage>&#8211;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.3233/NPM-180154</pub-id>.<pub-id pub-id-type="pmid">32280068</pub-id><pub-id pub-id-type="pmcid">PMC7242835</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roze</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Ancel</surname><given-names>P-Y</given-names></string-name>, <string-name name-style="western"><surname>Lepage</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Martin-Marchand</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Al Nabhani</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Delannoy</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Picaud</surname><given-names>J-C</given-names></string-name>, <string-name name-style="western"><surname>Lapillonne</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Aires</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Durox</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants</article-title>. <source>Am J Clin Nutr</source>. <year>2017</year>;<volume>106</volume>(<issue>3</issue>):<fpage>821</fpage>&#8211;<lpage>830</lpage>. doi: <pub-id pub-id-type="doi">10.3945/ajcn.117.152967</pub-id>.<pub-id pub-id-type="pmid">28659297</pub-id><pub-id pub-id-type="pmcid">PMC5573022</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yang</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Corwin</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Brennan</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Jordan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Murphy</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Dunlop</surname><given-names>A</given-names></string-name></person-group>. <article-title>The infant microbiome: implications for infant health and neurocognitive development</article-title>. <source>Nurs Res</source>. <year>2016</year>;<volume>65</volume>(<issue>1</issue>):<fpage>76</fpage>&#8211;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1097/NNR.0000000000000133</pub-id>.<pub-id pub-id-type="pmid">26657483</pub-id><pub-id pub-id-type="pmcid">PMC4681407</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gritz</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Bhandari</surname><given-names>V</given-names></string-name></person-group>. <article-title>The human neonatal gut microbiome: a brief review</article-title>. <source>Front Pediatr</source>. <year>2015</year>;<volume>3</volume>:<fpage>17</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fped.2015.00017</pub-id>.<pub-id pub-id-type="pmid">25798435</pub-id><pub-id pub-id-type="pmcid">PMC4350424</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kish</surname><given-names>MZ</given-names></string-name></person-group>. <article-title>Improving preterm infant outcomes: implementing an evidence-based oral feeding advancement protocol in the neonatal intensive care unit</article-title>. <source>Adv Neonatal Care</source>. <year>2014</year>;<volume>14</volume>(<issue>5</issue>):<fpage>346</fpage>&#8211;<lpage>353</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ANC.0000000000000099</pub-id>.<pub-id pub-id-type="pmid">24979099</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McCain</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Gartside</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Greenberg</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lott</surname><given-names>JW</given-names></string-name></person-group>. <article-title>A feeding protocol for healthy preterm infants that shortens time to oral feeding</article-title>. <source>J Pediatr</source>. <year>2001</year>;<volume>139</volume>(<issue>3</issue>):<fpage>374</fpage>&#8211;<lpage>379</lpage>. doi: <pub-id pub-id-type="doi">10.1067/mpd.2001.117077</pub-id>.<pub-id pub-id-type="pmid">11562616</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Good</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sodhi</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Egan</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Afrazi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Branca</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Prindle</surname><given-names>T</given-names></string-name>, et al</person-group>. <article-title>Breast milk protects against the development of necrotizing enterocolitis through inhibition of toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor</article-title>. <source>Mucosal Immunol</source>. <year>2015</year>;<volume>8</volume>(<issue>5</issue>):<fpage>1166</fpage>&#8211;<lpage>1179</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mi.2015.30</pub-id>.<pub-id pub-id-type="pmid">25899687</pub-id><pub-id pub-id-type="pmcid">PMC4540669</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Saleem</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Okogbule-Wonodi</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Fasano</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Magder</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Ravel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kapoor</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Viscardi</surname><given-names>RM</given-names></string-name></person-group>. <article-title>Intestinal barrier maturation in very low birthweight infants: relationship to feeding and antibiotic exposure</article-title>. <source>J Pediatr</source>. <year>2017</year>;<volume>183</volume>:<fpage>31</fpage>&#8211;<lpage>36 e1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpeds.2017.01.013</pub-id>.<pub-id pub-id-type="pmid">28159311</pub-id><pub-id pub-id-type="pmcid">PMC5367935</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bering</surname><given-names>SB</given-names></string-name></person-group>. <article-title>Human milk oligosaccharides to prevent gut dysfunction and necrotizing enterocolitis in preterm neonates</article-title>. <source>Nutrients</source>. <year>2018</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1461</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu10101461</pub-id>.<pub-id pub-id-type="pmid">30297668</pub-id><pub-id pub-id-type="pmcid">PMC6213229</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sodhi</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Wipf</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fulton</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Kovler</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ni&#241;o</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Banfield</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Werts</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Ladd</surname><given-names>MR</given-names></string-name>, et al</person-group>. <article-title>The human milk oligosaccharides 2&#8217;-fucosyllactose and 6&#8217;-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling</article-title>. <source>Pediatr Res</source>. <year>2021</year>;<volume>89</volume>(<issue>1</issue>):<fpage>91</fpage>&#8211;<lpage>101</lpage>.<pub-id pub-id-type="pmid">32221473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41390-020-0852-3</pub-id><pub-id pub-id-type="pmcid">PMC7529714</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kumbhare</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>W-D</given-names></string-name>, <string-name name-style="western"><surname>Fast</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bonner</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Jong</surname><given-names>G&#8216;</given-names></string-name>, <string-name name-style="western"><surname>Van Domselaar</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Graham</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Narvey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Azad</surname><given-names>MB</given-names></string-name></person-group>. <article-title>Source of human milk (mother or donor) is more important than fortifier type (human or bovine) in shaping the preterm infant microbiome</article-title>. <source>Cell Rep Med</source>. <year>2022</year>;<volume>3</volume>(<issue>9</issue>):<fpage>100712</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100712</pub-id>.<pub-id pub-id-type="pmid">36029771</pub-id><pub-id pub-id-type="pmcid">PMC9512671</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chong</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>LTH</given-names></string-name>, <string-name name-style="western"><surname>Law</surname><given-names>JWF</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname><given-names>K-W</given-names></string-name>, <string-name name-style="western"><surname>Ratnasingam</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ab Mutalib</surname><given-names>N-S</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>L-H</given-names></string-name>, <string-name name-style="western"><surname>Letchumanan</surname><given-names>V</given-names></string-name></person-group>. <article-title>Exploring the potential of human milk and formula milk on infants</article-title>. <source>Gut Health Nutrients</source>. <year>2022</year>;<volume>14</volume>(<issue>17</issue>):<fpage>3554</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14173554</pub-id>.<pub-id pub-id-type="pmid">36079814</pub-id><pub-id pub-id-type="pmcid">PMC9460722</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pivrncova</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Kotaskova</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Thon</surname><given-names>V</given-names></string-name></person-group>. <article-title>Neonatal diet and gut microbiome development after C-section during the first three months after birth: a systematic review</article-title>. <source>Front Nutr</source>. <year>2022</year>;<volume>9</volume>:<fpage>941549</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2022.941549</pub-id>.<pub-id pub-id-type="pmid">35967823</pub-id><pub-id pub-id-type="pmcid">PMC9364824</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Masi</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Beck</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Perry</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Granger</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Hiorns</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Bode</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Embleton</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Berrington</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Human milk microbiota, oligosaccharide profiles, and infant gut microbiome in preterm infants diagnosed with necrotizing enterocolitis</article-title>. <source>Cell Rep Med</source>. <year>2024</year>;<volume>5</volume>(<issue>9</issue>):<fpage>101708</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.xcrm.2024.101708</pub-id>.<pub-id pub-id-type="pmid">39216480</pub-id><pub-id pub-id-type="pmcid">PMC11524953</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Robinson</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Calkins</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Cober</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Falciglia</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Church</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Mey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>McKeever</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sentongo</surname><given-names>T</given-names></string-name></person-group>. <article-title>Guidelines for parenteral nutrition in preterm infants: the American Society for Parenteral and Enteral Nutrition</article-title>. <source>JPEN J Parenter Enter Nutr</source>. <year>2023</year>;<volume>47</volume>(<issue>7</issue>):<fpage>830</fpage>&#8211;<lpage>858</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jpen.2550</pub-id>.<pub-id pub-id-type="pmid">37610837</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cerdo</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Santos</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Rodr&#237;guez-P&#246;hnlein</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Ricobaraza</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nieto-Ru&#237;z</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Berm&#250;dez</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Campoy</surname><given-names>C</given-names></string-name></person-group>. <article-title>Impact of total parenteral nutrition on gut microbiota in pediatric population suffering intestinal disorders</article-title>. <source>Nutrients</source>. <year>2022</year>;<volume>14</volume>(<issue>21</issue>):<fpage>4691</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14214691</pub-id>.<pub-id pub-id-type="pmid">36364953</pub-id><pub-id pub-id-type="pmcid">PMC9658482</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chaaban</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Burge</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Eckert</surname><given-names>JV</given-names></string-name>, <string-name name-style="western"><surname>Lupu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Keshari</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Silasi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Regmi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Trammell</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dyer</surname><given-names>D</given-names></string-name>, et al</person-group>. <article-title>Early antibiotic exposure alters intestinal development and increases susceptibility to necrotizing enterocolitis: a mechanistic study</article-title>. <source>Microorganisms</source>. <year>2022</year>;<volume>10</volume>(<issue>3</issue>):<fpage>519</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms10030519</pub-id>.<pub-id pub-id-type="pmid">35336095</pub-id><pub-id pub-id-type="pmcid">PMC8951210</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martinez de Tejada</surname><given-names>B</given-names></string-name></person-group>. <article-title>Antibiotic use and misuse during pregnancy and delivery: benefits and risks</article-title>. <source>Int J Environ Res Public Health</source>. <year>2014</year>;<volume>11</volume>(<issue>8</issue>):<fpage>7993</fpage>&#8211;<lpage>8009</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph110807993</pub-id>.<pub-id pub-id-type="pmid">25105549</pub-id><pub-id pub-id-type="pmcid">PMC4143845</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gasparrini</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Crofts</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Gibson</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Tarr</surname><given-names>PI</given-names></string-name>, <string-name name-style="western"><surname>Warner</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Dantas</surname><given-names>G</given-names></string-name></person-group>. <article-title>Antibiotic perturbation of the preterm infant gut microbiome and resistome</article-title>. <source>Gut Microbes</source>. <year>2016</year>;<volume>7</volume>(<issue>5</issue>):<fpage>443</fpage>&#8211;<lpage>449</lpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2016.1218584</pub-id>.<pub-id pub-id-type="pmid">27472377</pub-id><pub-id pub-id-type="pmcid">PMC5154371</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xing</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>Y-Q</given-names></string-name></person-group>. <article-title>Probiotics to prevent necrotizing enterocolitis and reduce mortality in neonates: a meta-analysis</article-title>. <source>Medicine (Baltimore)</source>. <year>2023</year>;<volume>102</volume>(<issue>8</issue>):<fpage>e32932</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000032932</pub-id>.<pub-id pub-id-type="pmid">36827026</pub-id><pub-id pub-id-type="pmcid">PMC11309691</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tian</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>M-F</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>H-M</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>M-Z</given-names></string-name>, <string-name name-style="western"><surname>Yue</surname><given-names>N-N</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>R-Y</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L-S</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>Y-J</given-names></string-name>, et al</person-group>. <article-title>Stem cell-derived intestinal organoids: a novel modality for IBD</article-title>. <source>Cell Death Discov</source>. <year>2023</year>;<volume>9</volume>(<issue>1</issue>):<fpage>255</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41420-023-01556-1</pub-id>.<pub-id pub-id-type="pmid">37479716</pub-id><pub-id pub-id-type="pmcid">PMC10362068</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cadete</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Koike</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hock</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>RY</given-names></string-name>, <string-name name-style="western"><surname>Botts</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Minich</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Alganabi</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>Impaired Wnt/beta-catenin pathway leads to dysfunction of intestinal regeneration during necrotizing enterocolitis</article-title>. <source>Cell Death Dis</source>. <year>2019</year>;<volume>10</volume>(<issue>10</issue>):<fpage>743</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-019-1987-1</pub-id>.<pub-id pub-id-type="pmid">31582728</pub-id><pub-id pub-id-type="pmcid">PMC6776513</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zong</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Toll-like receptor 4-mediated necroptosis in the development of necrotizing enterocolitis</article-title>. <source>Pediatr Res</source>. <year>2022</year>;<volume>91</volume>(<issue>1</issue>):<fpage>73</fpage>&#8211;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-021-01457-y</pub-id>.<pub-id pub-id-type="pmid">33731807</pub-id><pub-id pub-id-type="pmcid">PMC8770135</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hackam</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Sodhi</surname><given-names>CP</given-names></string-name></person-group>. <article-title>Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2022</year>;<volume>19</volume>(<issue>7</issue>):<fpage>468</fpage>&#8211;<lpage>479</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41575-022-00594-x</pub-id>.<pub-id pub-id-type="pmid">35347256</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Frosali</surname><given-names>S</given-names></string-name> , <string-name name-style="western"><surname>Pagliari</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gambassi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Landolfi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Pandolfi</surname><given-names>F</given-names></string-name> , <string-name name-style="western"><surname>Cianci</surname><given-names>R</given-names></string-name></person-group>. <article-title>How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology</article-title>. <source>J Immunol Res</source>. <year>2015</year>;<volume>2015</volume>:<fpage>489821</fpage>. doi:<pub-id pub-id-type="doi">10.1155/2015/489821</pub-id>. PMCID: <comment>PMC4452102.</comment> PMID: 26090491.<pub-id pub-id-type="pmid">26090491</pub-id><pub-id pub-id-type="pmcid">PMC4452102</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Buonpane</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wood</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ares</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Klonoski</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Rock1 inhibitor stabilizes E-cadherin and improves barrier function in experimental necrotizing enterocolitis</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2020</year>;<volume>318</volume>(<issue>4</issue>):<fpage>G781</fpage>&#8211;<lpage>G792</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00195.2019</pub-id>.<pub-id pub-id-type="pmid">32090605</pub-id><pub-id pub-id-type="pmcid">PMC7191467</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wei</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>L</given-names></string-name></person-group>. <article-title>Rip3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-kappaB pathway in macrophages</article-title>. <source>Faseb J</source>. <year>2019</year>;<volume>33</volume>(<issue>10</issue>):<fpage>11180</fpage>&#8211;<lpage>11193</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.201900752R</pub-id>.<pub-id pub-id-type="pmid">31295018</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Xiang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Ouyang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization</article-title>. <source>Biochem Pharmacol</source>. <year>2022</year>;<volume>201</volume>:<fpage>115077</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2022.115077</pub-id>.<pub-id pub-id-type="pmid">35537530</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bankole</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Read</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Neves</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Garnett</surname><given-names>JA</given-names></string-name></person-group>. <article-title>The relationship between mucins and ulcerative colitis: a systematic review</article-title>. <source>J Clin Med</source>. <year>2021</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1935</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm10091935</pub-id>.<pub-id pub-id-type="pmid">33946184</pub-id><pub-id pub-id-type="pmcid">PMC8125602</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Breugelmans</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Arras</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Boen</surname><given-names>L-E</given-names></string-name>, <string-name name-style="western"><surname>Borms</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Kamperdijk</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>De Man</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Van de Vijver</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Van Gils</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>De Winter</surname><given-names>BY</given-names></string-name>, <string-name name-style="western"><surname>Moes</surname><given-names>N</given-names></string-name>, et al</person-group>. <article-title>Aberrant mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity</article-title>. <source>Inflamm Bowel Dis</source>. <year>2023</year>;<volume>29</volume>(<issue>4</issue>):<fpage>589</fpage>&#8211;<lpage>601</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ibd/izac217</pub-id>.<pub-id pub-id-type="pmid">36239641</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singh</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Carroll-Portillo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Coffman</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ritz</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name></person-group>. <article-title>Intestinal alkaline phosphatase exerts anti-inflammatory effects against lipopolysaccharide by inducing autophagy</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3107</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-59474-6</pub-id>.<pub-id pub-id-type="pmid">32080230</pub-id><pub-id pub-id-type="pmcid">PMC7033233</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fawley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gourlay</surname><given-names>DM</given-names></string-name></person-group>. <article-title>Intestinal alkaline phosphatase: a summary of its role in clinical disease</article-title>. <source>J Surg Res</source>. <year>2016</year>;<volume>202</volume>(<issue>1</issue>):<fpage>225</fpage>&#8211;<lpage>234</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jss.2015.12.008</pub-id>.<pub-id pub-id-type="pmid">27083970</pub-id><pub-id pub-id-type="pmcid">PMC4834149</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Martins</surname><given-names>RDS</given-names></string-name>, <string-name name-style="western"><surname>Hulscher</surname><given-names>JBF</given-names></string-name>, <string-name name-style="western"><surname>Timmer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kooi</surname><given-names>EMW</given-names></string-name>, <string-name name-style="western"><surname>Poelstra</surname><given-names>K</given-names></string-name></person-group>. <article-title>Necrotizing enterocolitis: a potential protective role for intestinal alkaline phosphatase as lipopolysaccharide detoxifying enzyme</article-title>. <source>Front Pediatr</source>. <year>2024</year>;<volume>12</volume>:<fpage>1401090</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fped.2024.1401090</pub-id>.<pub-id pub-id-type="pmid">38745834</pub-id><pub-id pub-id-type="pmcid">PMC11091495</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Merigo</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Brandolese</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Facchin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Missaggia</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bernardi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Boschi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>D&#8217;Inc&#224;</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Savarino</surname><given-names>EV</given-names></string-name>, <string-name name-style="western"><surname>Sbarbati</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sturniolo</surname><given-names>GC</given-names></string-name></person-group>. <article-title>Glucose transporter expression in the human colon</article-title>. <source>World J Gastroenterol</source>. <year>2018</year>;<volume>24</volume>(<issue>7</issue>):<fpage>775</fpage>&#8211;<lpage>793</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v24.i7.775</pub-id>.<pub-id pub-id-type="pmid">29467549</pub-id><pub-id pub-id-type="pmcid">PMC5807937</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Che</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname><given-names>Z</given-names></string-name>, et al</person-group>. <article-title>Fecal bacteria and metabolite responses to dietary lysozyme in a sow model from late gestation until lactation</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3210</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-60131-1</pub-id>.<pub-id pub-id-type="pmid">32081946</pub-id><pub-id pub-id-type="pmcid">PMC7035255</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bel</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pendse</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ruhn</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Hassell</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Leal</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Winter</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Xavier</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Hooper</surname><given-names>LV</given-names></string-name></person-group>. <article-title>Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine</article-title>. <source>Science</source>. <year>2017</year>;<volume>357</volume>(<issue>6355</issue>):<fpage>1047</fpage>&#8211;<lpage>1052</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aal4677</pub-id>.<pub-id pub-id-type="pmid">28751470</pub-id><pub-id pub-id-type="pmcid">PMC5702267</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schaart</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>de Bruijn</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Bouwman</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>de Krijger</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>van Goudoever</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Tibboel</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Renes</surname><given-names>IB</given-names></string-name></person-group>. <article-title>Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2009</year>;<volume>49</volume>(<issue>1</issue>):<fpage>31</fpage>&#8211;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MPG.0b013e318186d341</pub-id>.<pub-id pub-id-type="pmid">19458550</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Arijs</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>De Hertogh</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lemaire</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Quintens</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Van Lommel</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Van Steen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Leemans</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Cleynen</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Van Assche</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Vermeire</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment</article-title>. <source>PLOS ONE</source>. <year>2009</year>;<volume>4</volume>(<issue>11</issue>):<fpage>e7984</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0007984</pub-id>.<pub-id pub-id-type="pmid">19956723</pub-id><pub-id pub-id-type="pmcid">PMC2776509</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mallow</surname><given-names>EB</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Salzman</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Russell</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>DeBerardinis</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Ruchelli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bevins</surname><given-names>CL</given-names></string-name></person-group>. <article-title>Human enteric defensins. Gene structure and developmental expression</article-title>. <source>J Biol Chem</source>. <year>1996</year>;<volume>271</volume>(<issue>8</issue>):<fpage>4038</fpage>&#8211;<lpage>4045</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.271.8.4038</pub-id>.<pub-id pub-id-type="pmid">8626737</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pedersen</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Prause</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Barr&#232;s</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Billestrup</surname><given-names>N</given-names></string-name></person-group>. <article-title>Butyrate inhibits IL-1beta-induced inflammatory gene expression by suppression of NF-kappaB activity in pancreatic beta cells</article-title>. <source>J Biol Chem</source>. <year>2022</year>;<volume>298</volume>(<issue>9</issue>):<fpage>102312</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jbc.2022.102312</pub-id>.<pub-id pub-id-type="pmid">35921894</pub-id><pub-id pub-id-type="pmcid">PMC9428856</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Q</given-names></string-name></person-group>. <article-title>The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects</article-title>. <source>Cell Death Discov</source>. <year>2023</year>;<volume>9</volume>(<issue>1</issue>):<fpage>361</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41420-023-01666-w</pub-id>.<pub-id pub-id-type="pmid">37773196</pub-id><pub-id pub-id-type="pmcid">PMC10541886</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chiu</surname><given-names>YH</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname><given-names>Y-J</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname><given-names>K-W</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>K-C</given-names></string-name></person-group>. <article-title>Preferential promotion of apoptosis of monocytes by Lactobacillus casei rhamnosus soluble factors</article-title>. <source>Clin Nutr</source>. <year>2010</year>;<volume>29</volume>(<issue>1</issue>):<fpage>131</fpage>&#8211;<lpage>140</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2009.07.004</pub-id>.<pub-id pub-id-type="pmid">19665262</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ma</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Piao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Mahfuz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name></person-group>. <article-title>The interaction among gut microbes, the intestinal barrier and short chain fatty acids</article-title>. <source>Anim Nutr</source>. <year>2022</year>;<volume>9</volume>:<fpage>159</fpage>&#8211;<lpage>174</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.aninu.2021.09.012</pub-id>.<pub-id pub-id-type="pmid">35573092</pub-id><pub-id pub-id-type="pmcid">PMC9079705</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mallicote</surname><given-names>MU</given-names></string-name>, <string-name name-style="western"><surname>Escobar</surname><given-names>OH</given-names></string-name>, <string-name name-style="western"><surname>Dossa</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gayer</surname><given-names>CP</given-names></string-name></person-group>. <article-title>Oleanolic acid confers protection in the experimental necrotizing enterocolitis neonatal rat pup model at low doses</article-title>. <source>J Am Coll Surgeons</source>. <year>2016</year>;<volume>223</volume>(<issue>4</issue>):<fpage>e158</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2016.08.403</pub-id>.</mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Michaels</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Madsen</surname><given-names>KL</given-names></string-name></person-group>. <article-title>Immunometabolism and microbial metabolites at the gut barrier: lessons for therapeutic intervention in inflammatory bowel disease</article-title>. <source>Mucosal Immunol</source>. <year>2023</year>;<volume>16</volume>(<issue>1</issue>):<fpage>72</fpage>&#8211;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mucimm.2022.11.001</pub-id>.<pub-id pub-id-type="pmid">36642380</pub-id></mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Niechcial</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schwarzfischer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wawrzyniak</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Atrott</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Laimbacher</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Morsy</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Katkeviciute</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>H&#228;fliger</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Westermann</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Akdis</surname><given-names>CA</given-names></string-name>, et al</person-group>. <article-title>Spermidine ameliorates colitis via induction of anti-inflammatory macrophages and prevention of intestinal dysbiosis</article-title>. <source>J Crohns Colitis</source>. <year>2023</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1489</fpage>&#8211;<lpage>1503</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjad058</pub-id>.<pub-id pub-id-type="pmid">36995738</pub-id><pub-id pub-id-type="pmcid">PMC10588784</pub-id></mixed-citation></ref><ref id="cit0101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fulton</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kovler</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Salazar</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Sampah</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Prindle</surname><given-names>T</given-names></string-name>, et al</person-group>. <article-title>Maternal aryl hydrocarbon receptor activation protects newborns against necrotizing enterocolitis</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1042</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-21356-4</pub-id>.<pub-id pub-id-type="pmid">33589625</pub-id><pub-id pub-id-type="pmcid">PMC7884836</pub-id></mixed-citation></ref><ref id="cit0102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alsharairi</surname><given-names>NA</given-names></string-name></person-group>. <article-title>Therapeutic potential of gut microbiota and its metabolite short-chain fatty acids in neonatal necrotizing enterocolitis</article-title>. <source>Life (Basel)</source>. <year>2023</year>;<volume>13</volume>(<issue>2</issue>):<fpage>561</fpage>. doi: <pub-id pub-id-type="doi">10.3390/life13020561</pub-id>.<pub-id pub-id-type="pmid">36836917</pub-id><pub-id pub-id-type="pmcid">PMC9959300</pub-id></mixed-citation></ref><ref id="cit0103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morrow</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Lagomarcino</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Schibler</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Taft</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Altaye</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wagner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gevers</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>DV</given-names></string-name>, et al</person-group>. <article-title>Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants</article-title>. <source>Microbiome</source>. <year>2013</year>;<volume>1</volume>(<issue>1</issue>):<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.1186/2049-2618-1-13</pub-id>.<pub-id pub-id-type="pmid">24450576</pub-id><pub-id pub-id-type="pmcid">PMC3971624</pub-id></mixed-citation></ref><ref id="cit0104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Caruso</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lo</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Nunez</surname><given-names>G</given-names></string-name></person-group>. <article-title>Host&#8211;microbiota interactions in inflammatory bowel disease</article-title>. <source>Nat Rev Immunol</source>. <year>2020</year>;<volume>20</volume>(<issue>7</issue>):<fpage>411</fpage>&#8211;<lpage>426</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41577-019-0268-7</pub-id>.<pub-id pub-id-type="pmid">32005980</pub-id></mixed-citation></ref><ref id="cit0105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sokol</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Pigneur</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Watterlot</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lakhdari</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Berm&#250;dez-Humar&#225;n</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Gratadoux</surname><given-names>J-J</given-names></string-name>, <string-name name-style="western"><surname>Blugeon</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bridonneau</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Furet</surname><given-names>J-P</given-names></string-name>, <string-name name-style="western"><surname>Corthier</surname><given-names>G</given-names></string-name>, et al</person-group>. <article-title>Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>43</issue>):<fpage>16731</fpage>&#8211;<lpage>16736</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0804812105</pub-id>.<pub-id pub-id-type="pmid">18936492</pub-id><pub-id pub-id-type="pmcid">PMC2575488</pub-id></mixed-citation></ref><ref id="cit0106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bjorkqvist</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Rangel</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Serrander</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Magnusson</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Halfvarson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nor&#233;n</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bergman-Jungestr&#246;m</surname><given-names>M</given-names></string-name></person-group>. <article-title>Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection</article-title>. <source>PLOS ONE</source>. <year>2021</year>;<volume>16</volume>(<issue>4</issue>):<fpage>e0249861</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0249861</pub-id>.<pub-id pub-id-type="pmid">33836037</pub-id><pub-id pub-id-type="pmcid">PMC8034738</pub-id></mixed-citation></ref><ref id="cit0107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity</article-title>. <source>Cell Mol Immunol</source>. <year>2023</year>;<volume>20</volume>(<issue>4</issue>):<fpage>341</fpage>&#8211;<lpage>350</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41423-023-00987-1</pub-id>.<pub-id pub-id-type="pmid">36854801</pub-id><pub-id pub-id-type="pmcid">PMC10066346</pub-id></mixed-citation></ref><ref id="cit0108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lassenius</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Fogarty</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Blaut</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Haimila</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Riittinen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Paju</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kirveskari</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>J&#228;rvel&#228;</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ahola</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Gordin</surname><given-names>D</given-names></string-name>, et al</person-group>. <article-title>Intestinal alkaline phosphatase at the crossroad of intestinal health and disease &#8211; a putative role in type 1 diabetes</article-title>. <source>J Intern Med</source>. <year>2017</year>;<volume>281</volume>(<issue>6</issue>):<fpage>586</fpage>&#8211;<lpage>600</lpage>. doi: <pub-id pub-id-type="doi">10.1111/joim.12607</pub-id>.<pub-id pub-id-type="pmid">28393441</pub-id></mixed-citation></ref><ref id="cit0109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bilski</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mazur-Bialy</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wojcik</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zahradnik-Bilska</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Brzozowski</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Magierowski</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Mach</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Magierowska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Brzozowski</surname><given-names>T</given-names></string-name></person-group>. <article-title>The role of intestinal alkaline phosphatase in inflammatory disorders of gastrointestinal tract</article-title>. <source>Mediators Inflamm</source>. <year>2017</year>;<volume>2017</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2017/9074601</pub-id>.<pub-id pub-id-type="pmcid">PMC5339520</pub-id><pub-id pub-id-type="pmid">28316376</pub-id></mixed-citation></ref><ref id="cit0110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Geng</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>F-Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z-F</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy</article-title>. <source>Front Mol Biosci</source>. <year>2021</year>;<volume>8</volume>:<fpage>634874</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmolb.2021.634874</pub-id>.<pub-id pub-id-type="pmid">33855046</pub-id><pub-id pub-id-type="pmcid">PMC8039130</pub-id></mixed-citation></ref><ref id="cit0111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ling</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>Q</given-names></string-name>, et al</person-group>. <article-title>Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2023</year>;<volume>13</volume>:<fpage>1119992</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2023.1119992</pub-id>.<pub-id pub-id-type="pmid">37265504</pub-id><pub-id pub-id-type="pmcid">PMC10229905</pub-id></mixed-citation></ref><ref id="cit0112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Park</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Jannasch</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Cooper</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>CH</given-names></string-name></person-group>. <article-title>Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway</article-title>. <source>Mucosal Immunol</source>. <year>2015</year>;<volume>8</volume>(<issue>1</issue>):<fpage>80</fpage>&#8211;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mi.2014.44</pub-id>.<pub-id pub-id-type="pmid">24917457</pub-id><pub-id pub-id-type="pmcid">PMC4263689</pub-id></mixed-citation></ref><ref id="cit0113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bui</surname><given-names>TNY</given-names></string-name>, <string-name name-style="western"><surname>Paul</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Guleria</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Toldi</surname><given-names>G</given-names></string-name></person-group>. <article-title>Short-chain fatty acids-a key link between the gut microbiome and T-lymphocytes in neonates?</article-title><source>Pediatr Res</source>. <year>2025</year>; doi: <pub-id pub-id-type="doi">10.1038/s41390-025-04075-0</pub-id>.<pub-id pub-id-type="pmid">40307498</pub-id></mixed-citation></ref><ref id="cit0114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Waligora-Dupriet</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Dugay</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Auzeil</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Nicolis</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Rabot</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Huerre</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Butel</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>Short-chain fatty acids and polyamines in the pathogenesis of necrotizing enterocolitis: kinetics aspects in gnotobiotic quails</article-title>. <source>Anaerobe</source>. <year>2009</year>;<volume>15</volume>(<issue>4</issue>):<fpage>138</fpage>&#8211;<lpage>144</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.anaerobe.2009.02.001</pub-id>.<pub-id pub-id-type="pmid">19233303</pub-id></mixed-citation></ref><ref id="cit0115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Venkatraman</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Menden</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Martinez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Umar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sampath</surname><given-names>V</given-names></string-name></person-group>. <article-title>Short-chain fatty acids ameliorate necrotizing enterocolitis-like intestinal injury through enhancing Notch1-mediated single immunoglobulin interleukin-1-related receptor, toll-interacting protein, and A20 induction</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2023</year>;<volume>324</volume>(<issue>1</issue>):<fpage>G24</fpage>&#8211;<lpage>g37</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00057.2022</pub-id>.<pub-id pub-id-type="pmid">36410023</pub-id><pub-id pub-id-type="pmcid">PMC9799135</pub-id></mixed-citation></ref><ref id="cit0116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wlodarska</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kolde</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>d&#8217;Hennezel</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Annand</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Heim</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Krastel</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Schmitt</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Omar</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Creasey</surname><given-names>EA</given-names></string-name>, et al</person-group>. <article-title>Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation</article-title>. <source>Cell Host Microbe</source>. <year>2017</year>;<volume>22</volume>(<issue>1</issue>):<fpage>25</fpage>&#8211;<lpage>37 e6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2017.06.007</pub-id>.<pub-id pub-id-type="pmid">28704649</pub-id><pub-id pub-id-type="pmcid">PMC5672633</pub-id></mixed-citation></ref><ref id="cit0117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Taleb</surname><given-names>S</given-names></string-name></person-group>. <article-title>Tryptophan dietary impacts gut barrier and metabolic diseases</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>2113</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.02113</pub-id>.<pub-id pub-id-type="pmid">31552046</pub-id><pub-id pub-id-type="pmcid">PMC6746884</pub-id></mixed-citation></ref><ref id="cit0118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Deianova</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>el Manouni el Hassani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Struijs</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Jansen</surname><given-names>EEW</given-names></string-name>, <string-name name-style="western"><surname>Bakkali</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>van de Wiel</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>de Boode</surname><given-names>WP</given-names></string-name>, <string-name name-style="western"><surname>Hulzebos</surname><given-names>CV</given-names></string-name>, <string-name name-style="western"><surname>van Kaam</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Kramer</surname><given-names>BW</given-names></string-name>, et al</person-group>. <article-title>Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case-control study</article-title>. <source>Sci Rep</source>. <year>2022</year>;<volume>12</volume>(<issue>1</issue>):<fpage>12310</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-022-16351-8</pub-id>.<pub-id pub-id-type="pmid">35853977</pub-id><pub-id pub-id-type="pmcid">PMC9296556</pub-id></mixed-citation></ref><ref id="cit0119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sommella</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Salviati</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Campiglia</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ganguli</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Djebali</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>WA</given-names></string-name></person-group>. <article-title>Indole-3-lactic acid, a metabolite of tryptophan, secreted by Bifidobacterium longum subspecies infantis is anti-inflammatory in the immature intestine</article-title>. <source>Pediatr Res</source>. <year>2020</year>;<volume>88</volume>(<issue>2</issue>):<fpage>209</fpage>&#8211;<lpage>217</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41390-019-0740-x</pub-id>.<pub-id pub-id-type="pmid">31945773</pub-id><pub-id pub-id-type="pmcid">PMC7363505</pub-id></mixed-citation></ref><ref id="cit0120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lamas</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Richard</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Leducq</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Pham</surname><given-names>H-P</given-names></string-name>, <string-name name-style="western"><surname>Michel</surname><given-names>M-L</given-names></string-name>, <string-name name-style="western"><surname>Da Costa</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Bridonneau</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Jegou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hoffmann</surname><given-names>TW</given-names></string-name>, <string-name name-style="western"><surname>Natividad</surname><given-names>JM</given-names></string-name>, et al</person-group>. <article-title>Card9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands</article-title>. <source>Nat Med</source>. <year>2016</year>;<volume>22</volume>(<issue>6</issue>):<fpage>598</fpage>&#8211;<lpage>605</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm.4102</pub-id>.<pub-id pub-id-type="pmid">27158904</pub-id><pub-id pub-id-type="pmcid">PMC5087285</pub-id></mixed-citation></ref><ref id="cit0121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lyu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name></person-group>. <article-title>The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective</article-title>. <source>Front Immunol</source>. <year>2023</year>;<volume>14</volume>:<fpage>1277102</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2023.1277102</pub-id>.<pub-id pub-id-type="pmid">37876938</pub-id><pub-id pub-id-type="pmcid">PMC10591221</pub-id></mixed-citation></ref><ref id="cit0122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>W</given-names></string-name>, et al</person-group>. <article-title>Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway</article-title>. <source>Gut Microbes</source>. <year>2024</year>;<volume>16</volume>(<issue>1</issue>):<fpage>2379566</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2024.2379566</pub-id>.<pub-id pub-id-type="pmid">39013030</pub-id><pub-id pub-id-type="pmcid">PMC11253882</pub-id></mixed-citation></ref><ref id="cit0123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thomas</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Modos</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rushbrook</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Powell</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Korcsmaros</surname><given-names>T</given-names></string-name></person-group>. <article-title>The emerging role of bile acids in the pathogenesis of inflammatory bowel disease</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<fpage>829525</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.829525</pub-id>.<pub-id pub-id-type="pmid">35185922</pub-id><pub-id pub-id-type="pmcid">PMC8850271</pub-id></mixed-citation></ref><ref id="cit0124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fleishman</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>S</given-names></string-name></person-group>. <article-title>Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets</article-title>. <source>Sig Transduct Target Ther</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>97</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41392-024-01811-6</pub-id>.<pub-id pub-id-type="pmcid">PMC11045871</pub-id><pub-id pub-id-type="pmid">38664391</pub-id></mixed-citation></ref><ref id="cit0125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wiredu Ocansey</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>F</given-names></string-name></person-group>. <article-title>Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer</article-title>. <source>Front Pharmacol</source>. <year>2022</year>;<volume>13</volume>:<fpage>1016836</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2022.1016836</pub-id>.<pub-id pub-id-type="pmid">36278234</pub-id><pub-id pub-id-type="pmcid">PMC9583386</pub-id></mixed-citation></ref><ref id="cit0126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Duboc</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Rajca</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rainteau</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Benarous</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Maubert</surname><given-names>M-A</given-names></string-name>, <string-name name-style="western"><surname>Quervain</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Barbu</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Humbert</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Despras</surname><given-names>G</given-names></string-name>, et al</person-group>. <article-title>Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases</article-title>. <source>Gut</source>. <year>2013</year>;<volume>62</volume>(<issue>4</issue>):<fpage>531</fpage>&#8211;<lpage>539</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2012-302578</pub-id>.<pub-id pub-id-type="pmid">22993202</pub-id></mixed-citation></ref><ref id="cit0127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Franzosa</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Sirota-Madi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Avila-Pacheco</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Fornelos</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Haiser</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Reinker</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Vatanen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Mallick</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>McIver</surname><given-names>LJ</given-names></string-name>, et al</person-group>. <article-title>Gut microbiome structure and metabolic activity in inflammatory bowel disease</article-title>. <source>Nat Microbiol</source>. <year>2019</year>;<volume>4</volume>(<issue>2</issue>):<fpage>293</fpage>&#8211;<lpage>305</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-018-0306-4</pub-id>.<pub-id pub-id-type="pmid">30531976</pub-id><pub-id pub-id-type="pmcid">PMC6342642</pub-id></mixed-citation></ref><ref id="cit0128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>van Best</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rolle-Kampczyk</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Schaap</surname><given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Basic</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Olde Damink</surname><given-names>SWM</given-names></string-name>, <string-name name-style="western"><surname>Bleich</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Savelkoul</surname><given-names>PHM</given-names></string-name>, <string-name name-style="western"><surname>von Bergen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Penders</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hornef</surname><given-names>MW</given-names></string-name></person-group>. <article-title>Bile acids drive the newborn&#8217;s gut microbiota maturation</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>3692</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-17183-8</pub-id>.<pub-id pub-id-type="pmid">32703946</pub-id><pub-id pub-id-type="pmcid">PMC7378201</pub-id></mixed-citation></ref><ref id="cit0129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Potential role of bile acids in the pathogenesis of necrotizing enterocolitis</article-title>. <source>Life Sci</source>. <year>2024</year>;<volume>336</volume>:<fpage>122279</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2023.122279</pub-id>.<pub-id pub-id-type="pmid">37995935</pub-id></mixed-citation></ref><ref id="cit0130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Halpern</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Holubec</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Saunders</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Dvorak</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Doelle</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Ballatori</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Dvorak</surname><given-names>B</given-names></string-name></person-group>. <article-title>Bile acids induce ileal damage during experimental necrotizing enterocolitis</article-title>. <source>Gastroenterology</source>. <year>2006</year>;<volume>130</volume>(<issue>2</issue>):<fpage>359</fpage>&#8211;<lpage>372</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2005.10.023</pub-id>.<pub-id pub-id-type="pmid">16472592</pub-id><pub-id pub-id-type="pmcid">PMC3417808</pub-id></mixed-citation></ref><ref id="cit0131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Knapp</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kehring</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Stepp</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Calton</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Gephart</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Bandlamuri</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Boyle</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Dietz</surname><given-names>GI</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Romo</surname><given-names>RE</given-names></string-name>, et al</person-group>. <article-title>Elevated coefficient of variation in total fecal bile acids precedes diagnosis of necrotizing enterocolitis</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>249</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-57178-0</pub-id>.<pub-id pub-id-type="pmid">31937876</pub-id><pub-id pub-id-type="pmcid">PMC6959237</pub-id></mixed-citation></ref><ref id="cit0132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O&#8217;Guinn</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Handler</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Mallicote</surname><given-names>MU</given-names></string-name>, <string-name name-style="western"><surname>Feliciano</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gayer</surname><given-names>CP</given-names></string-name></person-group>. <article-title>Fxr deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2024</year>;<volume>327</volume>(<issue>2</issue>):<fpage>G175</fpage>&#8211;<lpage>G187</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00063.2024</pub-id>.<pub-id pub-id-type="pmid">38860296</pub-id><pub-id pub-id-type="pmcid">PMC11427094</pub-id></mixed-citation></ref><ref id="cit0133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Evans</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Misyak</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Schmelz</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Guri</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Hontecillas</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bassaganya-Riera</surname><given-names>J</given-names></string-name></person-group>. <article-title>Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma</article-title>. <source>J Nutr</source>. <year>2010</year>;<volume>140</volume>(<issue>3</issue>):<fpage>515</fpage>&#8211;<lpage>521</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.109.115642</pub-id>.<pub-id pub-id-type="pmid">20089779</pub-id><pub-id pub-id-type="pmcid">PMC2821885</pub-id></mixed-citation></ref><ref id="cit0134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bassaganya-Riera</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hontecillas</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Horne</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Sandridge</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Herfarth</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Bloomfeld</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Isaacs</surname><given-names>KL</given-names></string-name></person-group>. <article-title>Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn&#8217;s disease</article-title>. <source>Clin Nutr</source>. <year>2012</year>;<volume>31</volume>(<issue>5</issue>):<fpage>721</fpage>&#8211;<lpage>727</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2012.03.002</pub-id>.<pub-id pub-id-type="pmid">22521469</pub-id></mixed-citation></ref><ref id="cit0135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jiang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>S</given-names></string-name></person-group>. <article-title>Conjugated linoleic acid ameliorates necrotizing enterocolitis by suppressing inflammatory responses and maintaining intestinal barrier integrity via the PPAR&#947;/NF&#954;B signaling pathway</article-title>. <source>J Funct Foods</source>. <year>2024</year>;<volume>123</volume>:<fpage>106581</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jff.2024.106581</pub-id>.</mixed-citation></ref><ref id="cit0136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moya-Camarena</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Heuvel</surname><given-names>JPV</given-names></string-name>, <string-name name-style="western"><surname>Blanchard</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Leesnitzer</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Belury</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha</article-title>. <source>J Lipid Res</source>. <year>1999</year>;<volume>40</volume>(<issue>8</issue>):<fpage>1426</fpage>&#8211;<lpage>1433</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0022-2275(20)33384-8</pub-id>.<pub-id pub-id-type="pmid">10428978</pub-id></mixed-citation></ref><ref id="cit0137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nakamura</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kurihara</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Takahashi</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ohashi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kimura</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Onuki</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kume</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sasazawa</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Furusawa</surname><given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>2105</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-22212-1</pub-id>.<pub-id pub-id-type="pmid">33833232</pub-id><pub-id pub-id-type="pmcid">PMC8032791</pub-id></mixed-citation></ref><ref id="cit0138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shah</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Swiatlo</surname><given-names>E</given-names></string-name></person-group>. <article-title>A multifaceted role for polyamines in bacterial pathogens</article-title>. <source>Mol Microbiol</source>. <year>2008</year>;<volume>68</volume>(<issue>1</issue>):<fpage>4</fpage>&#8211;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06126.x</pub-id>.<pub-id pub-id-type="pmid">18405343</pub-id></mixed-citation></ref><ref id="cit0139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wei</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name></person-group>. <article-title>Identifying polyamine related biomarkers in diagnosis and treatment of ulcerative colitis by integrating bulk and single-cell sequencing data</article-title>. <source>Sci Rep</source>. <year>2024</year>;<volume>14</volume>(<issue>1</issue>):<fpage>18094</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-69322-6</pub-id>.<pub-id pub-id-type="pmid">39103474</pub-id><pub-id pub-id-type="pmcid">PMC11300856</pub-id></mixed-citation></ref><ref id="cit0140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nishiguchi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Taguchi</surname><given-names>T</given-names></string-name></person-group>. <article-title>Inflammation-targeting polyamine nanomedicines for the treatment of ulcerative colitis</article-title>. <source>J Mater Chem B</source>. <year>2023</year>;<volume>11</volume>(<issue>18</issue>):<fpage>4005</fpage>&#8211;<lpage>4013</lpage>. doi: <pub-id pub-id-type="doi">10.1039/D3TB00424D</pub-id>.<pub-id pub-id-type="pmid">37039159</pub-id></mixed-citation></ref><ref id="cit0141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Forget</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Degraeuwe</surname><given-names>PLJ</given-names></string-name>, <string-name name-style="western"><surname>Smeets</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Deutz</surname><given-names>NEP</given-names></string-name></person-group>. <article-title>Fasting gastric fluid and fecal polyamine concentrations in premature infants</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>1997</year>;<volume>24</volume>(<issue>4</issue>):<fpage>389</fpage>&#8211;<lpage>392</lpage>. doi: <pub-id pub-id-type="doi">10.1002/j.1536-4801.1997.tb00448.x</pub-id>.<pub-id pub-id-type="pmid">9144120</pub-id></mixed-citation></ref><ref id="cit0142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Plamada</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Vodnar</surname><given-names>DC</given-names></string-name></person-group>. <article-title>Polyphenols-gut microbiota interrelationship: a transition to a new generation of prebiotics</article-title>. <source>Nutrients</source>. <year>2021</year>;<volume>14</volume>(<issue>1</issue>):<fpage>137</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14010137</pub-id>.<pub-id pub-id-type="pmid">35011012</pub-id><pub-id pub-id-type="pmcid">PMC8747136</pub-id></mixed-citation></ref><ref id="cit0143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Farag</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Simal-Gandara</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>H</given-names></string-name></person-group>. <article-title>Dietary polyphenols ameliorate inflammatory bowel diseases: advances and future perspectives to maximize their nutraceutical applications</article-title>. <source>Phytochem Rev</source>. <year>2023</year>;<volume>24</volume>(<issue>2</issue>):<fpage>1227</fpage>&#8211;<lpage>1259</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11101-023-09866-z</pub-id>.</mixed-citation></ref><ref id="cit0144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Caban</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lewandowska</surname><given-names>U</given-names></string-name></person-group>. <article-title>Polyphenols and the potential mechanisms of their therapeutic benefits against inflammatory bowel diseases</article-title>. <source>J Funct Foods</source>. <year>2022</year>;<volume>95</volume>:<fpage>105181</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jff.2022.105181</pub-id>.</mixed-citation></ref><ref id="cit0145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Han</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Pang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name></person-group>. <article-title>Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation</article-title>. <source>Cell Death Dis</source>. <year>2023</year>;<volume>14</volume>(<issue>10</issue>):<fpage>656</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-023-06190-4</pub-id>.<pub-id pub-id-type="pmid">37813835</pub-id><pub-id pub-id-type="pmcid">PMC10562418</pub-id></mixed-citation></ref><ref id="cit0146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ai</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Y</given-names></string-name></person-group>. <article-title>Beta-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota</article-title>. <source>J Transl Med</source>. <year>2023</year>;<volume>21</volume>(<issue>1</issue>):<fpage>14</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-022-03866-x</pub-id>.<pub-id pub-id-type="pmid">36627673</pub-id><pub-id pub-id-type="pmcid">PMC9830848</pub-id></mixed-citation></ref><ref id="cit0147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>WA</given-names></string-name></person-group>. <article-title>Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2021</year>;<volume>320</volume>(<issue>4</issue>):<fpage>G521</fpage>&#8211;<lpage>G530</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00279.2020</pub-id>.<pub-id pub-id-type="pmid">33085904</pub-id><pub-id pub-id-type="pmcid">PMC8238162</pub-id></mixed-citation></ref><ref id="cit0148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nolan</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Mihi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Agrawal</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Rimer</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Bidani</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Gale</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Goree</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Lanik</surname><given-names>WE</given-names></string-name>, et al</person-group>. <article-title>Indole-3-carbinol-dependent aryl hydrocarbon receptor signaling attenuates the inflammatory response in experimental necrotizing enterocolitis</article-title>. <source>Immunohorizons</source>. <year>2021</year>;<volume>5</volume>(<issue>4</issue>):<fpage>193</fpage>&#8211;<lpage>209</lpage>. doi: <pub-id pub-id-type="doi">10.4049/immunohorizons.2100018</pub-id>.<pub-id pub-id-type="pmid">33906960</pub-id><pub-id pub-id-type="pmcid">PMC8173979</pub-id></mixed-citation></ref><ref id="cit0149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>S&#246;nmezg&#246;z</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Takci</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>G&#252;l</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Uysal</surname><given-names>M</given-names></string-name></person-group>. <article-title>Ursodeoxycholic acid protects neonatal rats from necrotizing enterocolitis: a biochemical, histopathological, and immunohistochemical study</article-title>. <source>J Matern Fetal Neonatal Med</source>. <year>2021</year>;<volume>34</volume>(<issue>22</issue>):<fpage>3761</fpage>&#8211;<lpage>3767</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14767058.2020.1818210</pub-id>.<pub-id pub-id-type="pmid">32954879</pub-id></mixed-citation></ref><ref id="cit0150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Calton</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Carothers</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ramamurthy</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jagadish</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Phanindra</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Garcia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Viswanathan</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Halpern</surname><given-names>MD</given-names></string-name></person-group>. <article-title>Clostridium scindens exacerbates experimental necrotizing enterocolitis via upregulation of the apical sodium-dependent bile acid transporter</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2024</year>;<volume>326</volume>(<issue>1</issue>):<fpage>G25</fpage>&#8211;<lpage>G37</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00102.2023</pub-id>.<pub-id pub-id-type="pmid">37933481</pub-id><pub-id pub-id-type="pmcid">PMC11208032</pub-id></mixed-citation></ref><ref id="cit0151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lai</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>Melatonin alleviates necrotizing enterocolitis by reducing bile acid levels through the SIRT1/FXR signalling axis</article-title>. <source>Int Immunopharmacol</source>. <year>2024</year>;<volume>128</volume>:<fpage>111360</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.intimp.2023.111360</pub-id>.<pub-id pub-id-type="pmid">38176339</pub-id></mixed-citation></ref><ref id="cit0152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Khalesi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Mazloomi Nobandegani</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Khosravi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Saboute</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Farahi</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Shakeri</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Allahqoli</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Alkatout</surname><given-names>I</given-names></string-name></person-group>. <article-title>Effect of maternal diet on any necrotizing enterocolitis in neonates: a randomized double-blind study</article-title>. <source>Breastfeed Med</source>. <year>2022</year>;<volume>17</volume>(<issue>8</issue>):<fpage>647</fpage>&#8211;<lpage>652</lpage>. doi: <pub-id pub-id-type="doi">10.1089/bfm.2021.0371</pub-id>.<pub-id pub-id-type="pmid">35613385</pub-id><pub-id pub-id-type="pmcid">PMC9419928</pub-id></mixed-citation></ref><ref id="cit0153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bernabe-Garc&#237;a</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Calder</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Villegas-Silva</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rodr&#237;guez-Cruz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ch&#225;vez-S&#225;nchez</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cruz-Reynoso</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mateos-S&#225;nchez</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lara-Flores</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Aguilera-Joaqu&#237;n</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>S&#225;nchez-Garc&#237;a</surname><given-names>L</given-names></string-name></person-group>. <article-title>Efficacy of docosahexaenoic acid for the prevention of necrotizing enterocolitis in preterm infants: a randomized clinical trial</article-title>. <source>Nutrients</source>. <year>2021</year>;<volume>13</volume>(<issue>2</issue>):<fpage>648</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13020648</pub-id>.<pub-id pub-id-type="pmid">33671220</pub-id><pub-id pub-id-type="pmcid">PMC7922869</pub-id></mixed-citation></ref><ref id="cit0154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rumph</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Stephens</surname><given-names>VR</given-names></string-name>, <string-name name-style="western"><surname>Ameli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gaines</surname><given-names>PN</given-names></string-name>, <string-name name-style="western"><surname>Osteen</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Bruner-Tran</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Nde</surname><given-names>PN</given-names></string-name></person-group>. <article-title>A paternal fish oil diet preconception modulates the gut microbiome and attenuates necrotizing enterocolitis in neonatal mice</article-title>. <source>Mar Drugs</source>. <year>2022</year>;<volume>20</volume>(<issue>6</issue>):<fpage>390</fpage>. doi: <pub-id pub-id-type="doi">10.3390/md20060390</pub-id>.<pub-id pub-id-type="pmid">35736193</pub-id><pub-id pub-id-type="pmcid">PMC9230221</pub-id></mixed-citation></ref><ref id="cit0155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hui</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Vestergaard</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kot</surname><given-names>WP</given-names></string-name>, <string-name name-style="western"><surname>Thymann</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Brunse</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>DS</given-names></string-name></person-group>. <article-title>Donor-dependent fecal microbiota transplantation efficacy against necrotizing enterocolitis in preterm pigs</article-title>. <source>NPJ Biofilms Microbiomes</source>. <year>2022</year>;<volume>8</volume>(<issue>1</issue>):<fpage>48</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41522-022-00310-2</pub-id>.<pub-id pub-id-type="pmid">35680942</pub-id><pub-id pub-id-type="pmcid">PMC9184500</pub-id></mixed-citation></ref><ref id="cit0156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Prado</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abatti</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Michels</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>C&#243;rneo</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cucker</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Borges</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dias</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rocha</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Dal-Pizzol</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>C</given-names></string-name></person-group>. <article-title>Comparative effects of fresh and sterile fecal microbiota transplantation in an experimental animal model of necrotizing enterocolitis</article-title>. <source>J Pediatr Surg</source>. <year>2022</year>;<volume>57</volume>(<issue>9</issue>):<fpage>183</fpage>&#8211;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpedsurg.2021.12.013</pub-id>.<pub-id pub-id-type="pmid">35058059</pub-id></mixed-citation></ref><ref id="cit0157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morgan</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Preidis</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Kashyap</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Weizman</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Sadeghirad</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Florez</surname><given-names>ID</given-names></string-name>, <string-name name-style="western"><surname>Foroutan</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Shahid</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zeraatkar</surname><given-names>D</given-names></string-name></person-group>. <article-title>Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials</article-title>. <source>Gastroenterology</source>. <year>2020</year>;<volume>159</volume>(<issue>2</issue>):<fpage>467</fpage>&#8211;<lpage>480</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2020.05.096</pub-id>.<pub-id pub-id-type="pmid">32592699</pub-id><pub-id pub-id-type="pmcid">PMC8014956</pub-id></mixed-citation></ref><ref id="cit0158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Culp</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></string-name></person-group>. <article-title>Cross-feeding in the gut microbiome: ecology and mechanisms</article-title>. <source>Cell Host Microbe</source>. <year>2023</year>;<volume>31</volume>(<issue>4</issue>):<fpage>485</fpage>&#8211;<lpage>499</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2023.03.016</pub-id>.<pub-id pub-id-type="pmid">37054671</pub-id><pub-id pub-id-type="pmcid">PMC10125260</pub-id></mixed-citation></ref><ref id="cit0159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Han</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>Z</given-names></string-name></person-group>. <article-title>The effectiveness of treatment with probiotics in preventing necrotizing enterocolitis and related mortality: results from an umbrella meta-analysis on meta-analyses of randomized controlled trials</article-title>. <source>BMC Gastroenterol</source>. <year>2025</year>;<volume>25</volume>(<issue>1</issue>):<fpage>245</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12876-025-03788-0</pub-id>.<pub-id pub-id-type="pmid">40217146</pub-id><pub-id pub-id-type="pmcid">PMC11987312</pub-id></mixed-citation></ref><ref id="cit0160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tennoune</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Andriamihaja</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Blachier</surname><given-names>F</given-names></string-name></person-group>. <article-title>Production of indole and indole-related compounds by the intestinal microbiota and consequences for the host: the good, the bad, and the ugly</article-title>. <source>Microorganisms</source>. <year>2022</year>;<volume>10</volume>(<issue>5</issue>):<fpage>930</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms10050930</pub-id>.<pub-id pub-id-type="pmid">35630374</pub-id><pub-id pub-id-type="pmcid">PMC9145683</pub-id></mixed-citation></ref><ref id="cit0161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>J</given-names></string-name></person-group>. <article-title>Indole as an intercellular signal in microbial communities</article-title>. <source>FEMS Microbiol Rev</source>. <year>2010</year>;<volume>34</volume>(<issue>4</issue>):<fpage>426</fpage>&#8211;<lpage>444</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-6976.2009.00204.x</pub-id>.<pub-id pub-id-type="pmid">20070374</pub-id></mixed-citation></ref><ref id="cit0162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Qiao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>X</given-names></string-name></person-group>. <article-title>Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding</article-title>. <source>Microbiome</source>. <year>2024</year>;<volume>12</volume>(<issue>1</issue>):<fpage>59</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40168-024-01750-y</pub-id>.<pub-id pub-id-type="pmid">38504383</pub-id><pub-id pub-id-type="pmcid">PMC10949743</pub-id></mixed-citation></ref><ref id="cit0163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ye</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Anjum</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Miao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name></person-group>. <article-title>Dual role of indoles derived from intestinal microbiota on human health</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<fpage>903526</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.903526</pub-id>.<pub-id pub-id-type="pmid">35784338</pub-id><pub-id pub-id-type="pmcid">PMC9248744</pub-id></mixed-citation></ref><ref id="cit0164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tarracchini</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Milani</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Longhi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fontana</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mancabelli</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pintus</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lugli</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Alessandri</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Anzalone</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Viappiani</surname><given-names>A</given-names></string-name>, et al</person-group>. <article-title>Unraveling the microbiome of necrotizing enterocolitis: insights in novel microbial and metabolomic biomarkers</article-title>. <source>Microbiol Spectr</source>. <year>2021</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e0117621</fpage>. doi: <pub-id pub-id-type="doi">10.1128/Spectrum.01176-21</pub-id>.<pub-id pub-id-type="pmid">34704805</pub-id><pub-id pub-id-type="pmcid">PMC8549755</pub-id></mixed-citation></ref><ref id="cit0165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gurien</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Stallings-Archer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>SD</given-names></string-name></person-group>. <article-title>Probiotic Lactococcus lactis decreases incidence and severity of necrotizing enterocolitis in a preterm animal model</article-title>. <source>J Neonatal Perinatal Med</source>. <year>2018</year>;<volume>11</volume>(<issue>1</issue>):<fpage>65</fpage>&#8211;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.3233/NPM-181740</pub-id>.<pub-id pub-id-type="pmid">29689748</pub-id></mixed-citation></ref><ref id="cit0166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fatheree</surname><given-names>NY</given-names></string-name>, <string-name name-style="western"><surname>Mangalat</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rhoads</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-&#954;B signaling in the intestine</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2012</year>;<volume>302</volume>(<issue>6</issue>):<fpage>G608</fpage>&#8211;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpgi.00266.2011</pub-id>.<pub-id pub-id-type="pmid">22207578</pub-id><pub-id pub-id-type="pmcid">PMC3311308</pub-id></mixed-citation></ref><ref id="cit0167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wilson</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bogie</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Chaaban</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Burge</surname><given-names>K</given-names></string-name></person-group>. <article-title>The nonbacterial microbiome: fungal and viral contributions to the preterm infant gut in health and disease</article-title>. <source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>4</issue>):<fpage>909</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11040909</pub-id>.<pub-id pub-id-type="pmid">37110332</pub-id><pub-id pub-id-type="pmcid">PMC10144239</pub-id></mixed-citation></ref><ref id="cit0168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Garmaeva</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Gulyaeva</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kuzub</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Spreckels</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Andreu-S&#225;nchez</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gacesa</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Vich Vila</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Brushett</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kruk</surname><given-names>M</given-names></string-name>, et al</person-group>. <article-title>Transmission and dynamics of mother-infant gut viruses during pregnancy and early life</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>1945</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-024-45257-4</pub-id>.<pub-id pub-id-type="pmid">38431663</pub-id><pub-id pub-id-type="pmcid">PMC10908809</pub-id></mixed-citation></ref><ref id="cit0169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name></person-group>. <article-title>The next generation fecal microbiota transplantation: to transplant bacteria or virome</article-title>. <source>Adv Sci (Weinh)</source>. <year>2023</year>;<volume>10</volume>(<issue>35</issue>):<fpage>e2301097</fpage>. doi: <pub-id pub-id-type="doi">10.1002/advs.202301097</pub-id>.<pub-id pub-id-type="pmid">37914662</pub-id><pub-id pub-id-type="pmcid">PMC10724401</pub-id></mixed-citation></ref><ref id="cit0170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name></person-group>. <article-title>The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease</article-title>. <source>Gut Microbes</source>. <year>2024</year>;<volume>16</volume>(<issue>1</issue>):<fpage>2440111</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2024.2440111</pub-id>.<pub-id pub-id-type="pmid">39676474</pub-id><pub-id pub-id-type="pmcid">PMC11651280</pub-id></mixed-citation></ref><ref id="cit0171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sarafidis</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Agakidou</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Kontou</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Agakidis</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Neu</surname><given-names>J</given-names></string-name></person-group>. <article-title>Struggling to understand the NEC spectrum-could the integration of metabolomics, clinical-laboratory data, and other emerging technologies help diagnosis?</article-title><source>Metabolites</source>. <year>2024</year>;<volume>14</volume>(<issue>10</issue>):<fpage>521</fpage>. doi: <pub-id pub-id-type="doi">10.3390/metabo14100521</pub-id>.<pub-id pub-id-type="pmid">39452903</pub-id><pub-id pub-id-type="pmcid">PMC11509608</pub-id></mixed-citation></ref><ref id="cit0172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Madsen</surname><given-names>LP</given-names></string-name>, <string-name name-style="western"><surname>Rasmussen</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Bjerregaard</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>N&#248;hr</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Ebbesen</surname><given-names>F</given-names></string-name></person-group>. <article-title>Impact of blood sampling in very preterm infants</article-title>. <source>Scand J Clin Lab Invest</source>. <year>2000</year>;<volume>60</volume>(<issue>2</issue>):<fpage>125</fpage>&#8211;<lpage>132</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00365510050184949</pub-id>.<pub-id pub-id-type="pmid">10817399</pub-id></mixed-citation></ref><ref id="cit0173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chapman</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Stewart</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Methodological challenges in neonatal microbiome research</article-title>. <source>Gut Microbes</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>2183687</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2023.2183687</pub-id>.<pub-id pub-id-type="pmid">36843005</pub-id><pub-id pub-id-type="pmcid">PMC9980642</pub-id></mixed-citation></ref><ref id="cit0174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhgun</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Ilina</surname><given-names>EN</given-names></string-name></person-group>. <article-title>Fecal metabolites as non-invasive biomarkers of gut diseases</article-title>. <source>Acta Naturae</source>. <year>2020</year>;<volume>12</volume>(<issue>2</issue>):<fpage>4</fpage>&#8211;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.32607/actanaturae.11151</pub-id>.<pub-id pub-id-type="pmcid">PMC7385093</pub-id><pub-id pub-id-type="pmid">32742723</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>